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Glioblastoma multiforme (GBM) is one of the most common and aggressive 
primary brain tumours, with a median patient survival time of 6-12 months in adults. 
It has been recently suggested that a typically small sub-population of brain tumour 
cells, in possession of certain defining properties of stem cells, is responsible for 
initiating and maintaining the tumour. More recent experiments have studied the 
interactions between this subpopulation of brain cancer cells and tumour 
microenvironmental factors such as hypoxia and high acidity. In this thesis a 
computational approach (based on Gillespie’s algorithm and cellular automata) is 
proposed to investigate the tumour heterogeneities that develop when exposed to 
various microenvironmental conditions of the cancerous tissue.  The results suggest 
that microenvironmental conditions highly affect the characterization of cancer cells, 
including the self-renewal, differentiation and dedifferentiation properties of cancer 
cells.   
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In spite of considerable improvements in medical technology, cancer prognosis 
and treatment remain some of the main challenges of modern medicine. Cancer is 
a disease characterized by uncontrolled replication of cells as a result of the 
accumulation of multiple genetic mutations. Despite widespread and significant 
studies on cancer, conventional treatments remain problematic, survival time is 
often quiet short and cancer metastasis and reoccurrence are frequently lethal.  
Central nervous system cancers (aka brain) cancers are growing neoplasms inside 
the cranium or in the central spinal canal. The critical role of the central nervous 
system, the short survival time, deadly invasiveness, and reoccurrence of cancers 
highlight the critical importance of the appropriate selection of brain cancer 
treatments. 
In-depth studies of cancer cell physiology reveal heterogeneities inside tumours 
and consequently, the results of studies conducted in the early 60s proposed that 
the physiological and functional heterogeneities inside the tumour may be 
explained by considering distinct subpopulations of cancer cells. These 
considerations lie at the heart of the cancer stem cell hypothesis.  
According to the cancer stem cell hypothesis, there is a subpopulation of cancer 
cells capable of tumour initiation, tumour maintenance, as well as differentiation 
into other progenitor cells, that play a critical role in invasion and metastasis 
[Reya et al. 2001, Singh et al. 2004, Dirks 2008]. The annotation of cancer stem 
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cells is due to their physiological and functional similarities to normal stem cells. 
Just like normal stem cells, cancer stem cells are capable of colony formation. 
Furthermore, normal and cancer stem cells may express similar cell surface 
markers. For instance, brain cancer and normal neural stem cells both express CD 
133+ on their membrane [Singh et al. 2004, 2003]. Similar to normal stem cells, 
cancer stem cells undergo three alternative division pathways: self-renewal, 
symmetric or asymmetric differentiations. The cells produced through self-
renewal inherit all the capabilities of their stem-like parent while differentiated 
children are more mature cells with a lower potential for proliferation.   
Recent studies have reported that the tumour microenvironment closely interacts 
with cancer cells. Hanahan and Weinberg [Hanahan and Weinberg 2000, Hanahan 
and Weinberg 2011] characterized all cancer cells by introducing six common 
features: proliferation inhibitors avoidance, apoptosis escape, self-sufficiency in 
proliferation, unlimited replication, promotion of angiogenesis, invasion and 
metastasis. All cancer cells possess most of the aforementioned capabilities.  In a 
most recent paper [Hanahan and Weinberg 2011], they discuss the central role 
played by the tumour microenvironment in promoting the cancerous properties of 
these cells. The peculiar properties of the tumour microenvironment (that are 
partially the result of the tangled and dysfunctional vascular network inside the 
tumour as well as the metabolic abnormalities of cancer cells) include hypoxia, 
elevated acidity, and high interstitial fluid pressure. 
Hypoxia and acidity, common features of the tumour microenvironment, can play 
a significant role in the progression of tumour malignancies through the 
upregulation of proliferation and the promotion of the cancer stem cell phenotype 
[McLendon and Rich 2011]. Recent studies have reported the observation of 
CD133+, brain cancer stem cell surface marker expression in cancer stem cell-
depleted cultures exposed to hypoxia and acidity [Seidel et al. 2010, Heddleston 
et al. 2009, Hjelmeland et al. 2011]. Thus, in investigating the dynamics of 
tumour heterogeneities and tumour progression, it seems that microenvironmental 
factors play a key role.  
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The diverse tumour microenvironment and varieties of cancer cells form a 
complex system of multi-variables. The interaction of cancer cells and the tumour 
microenvironment complicates the problem further. The study of such a complex 
system requires powerful tools that can handle multiple variables with ease and 
can be tuned to satisfy biological considerations. Mathematical and 
computational models grounded on experimental studies have proved invaluable 
in studying complicated biological systems of many variables in order to provide 
a better understanding of the whole system. In addition, they can often capture 
the complex interaction of the variables, and thus provide the means for an in-
depth study of a particular part of the system. Mathematical and computational 
models are also proving to be increasingly useful in predicting the behaviour of 
biological systems, in making hypotheses and in designing appropriate biological 
experiments to test these hypotheses.  
In this thesis, we propose a mathematical model and use computational 
methodologies in order to investigate tumour heterogeneities, with an emphasis 
on the interaction of tumour microenvironmental factors, hypoxia and acidity, 
with cancer stem and non-stem cells. The model attempts to capture the dynamics 
of a heterogeneous population of cancer cells by including the self-renewal, 
symmetric or asymmetric differentiation of cancer stem cells and the division or 
dedifferentiation of non-stem cancer cells on exposure to various levels of 
hypoxia and acidity.  Chapter 2 briefly reviews the biological background 
knowledge of cancers, brain cancers, the tumour microenvironment, cancer cell 
heterogeneities, and the interactions between cancer cells and the tumour 
microenvironment. In chapter 2, we also cover the relevant issues and biological 
prerequisites necessary to set up the mathematical model. The first section of this 
chapter is devoted to introducing the general concept of cancer, characteristics of 
cancer cells, and different types of cancer with a focus on brain cancer and the 
special case of glioblastoma multiforme.  In the second section, we provide an 
overall picture of the tumour microenvironment. Starting with abnormal and 
sustained tumour angiogenesis, one of the basic reasons for tumour 
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microenvironment abnormalities, we discuss the phenomenon of hypoxia, 
mechanisms underlying the cancer cell response to hypoxic conditions and 
consequences promoted by the hypoxic environment. The low pH levels 
characteristic of the tumour microenvironment is reviewed, followed by a brief 
discussion of cancer cell metabolisms and the effects of different metabolic 
pathways on microenvironmental acidity. Finally, the high interstitial pressure of 
tumour tissues is considered. The second section of chapter 2 is devoted to a 
discussion of the cancer stem cell hypothesis. As biological prerequisites of the 
model construction, the current method of identification of brain cancer stem 
cells through the expression of CD133+ is discussed along with a discussion of 
the interaction of cancer stem cell with tumour vascular niches, hypoxia and high 
acidity. The third chapter starts with a brief review of mathematical cancer 
growth models. This consists of model categorization and a review of previous 
work on tumour growth dynamics. The fundamental construction of the model 
and assumptions is preceded by a discussion of possible division pathways of 
cancer stem and non-stem cells. In the second section of chapter 3, the 
preliminary model of cancer cell division pathways is expanded to encompass the 
suggested phenotypic pattern of cancer cells. After developing the mathematical 
framework of the model, we construct the master equation governing transition 
(division) pathways of cancer cells, in section 3.  We use a stochastic approach to 
gain a better understanding of the cellular heterogeneities inside the tumour. 
Thereafter, we use two steps of filtration of transition rates (out of a brute force 
process) to provide matching results with biological data, segregated into 
different microenvironmental conditions (including hypoxic, acidic, acidic-
hypoxic and normal conditions). In the first step, realizations are aimed to 
reproduce the same fraction of cancer stem cells as reported in biological 
experiments and in the second part, the ability of the system to form neurospheres 
is taken into account. The initial conditions and constraints for the simulations are 
tuned to match the initial conditions of the relevant biological experiments. 
Finally, the results are presented and discussed. We also draw conclusion about 
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the effects of hypoxia and acidity as well as the simultaneous exposure of acidity 
and hypoxia on the transition rates of cancer cells and consequently on the 
tumour heterogeneities. The last chapter demonstrates the result of the 
implementation of the obtained transition rates under specific tumour 
microenvironmental conditions in the proposed cellular automata model that can 
mimic the behaviour of cancer cells in tumour tissue. The cellular automata 
model is equipped with a pushing mechanism that under specific circumstances 
enables the central cells to proliferate. The tumour microenvironmental 
conditions, including oxygen and glucose distribution, metabolic recruitment 
pattern of the tumour tissue and subsequent pH distribution, are added to the 
model and interact with the cellular automata. The distribution map of different 
cell phenotypes are provided along with the corresponding nutrient distribution, 
in the results section. At the end of the chapter 4, the same results as the third 
section of chapter 3 are confirmed through the realizations of the cellular 




























2. Biological Background 
2.1. Introduction to cancer 
Cancer is a large family of diseases, over 100 different types [Hanahan and 
Weinberg 2000], characterized by uncontrolled division of abnormal cells, which 
are capable of invading surrounding tissues. Cancer cells may also spread to 
other organs of the body through blood and lymph vessels (metastasis). One may 
consider a tumour as an abnormal organ initiated by cancerous cells that through 
the accumulation of multiple mutations, have gained the ability of unbounded 
replication.  
A large body of ongoing cancer research has been dedicated to identifying the 
dynamics of genetic changes that lead to cancer [Hanahan and Weinberg 2000]. 
Although these findings are large steps in recognizing relevant molecular and 
biochemical pathways, the incompatibility of experimental model cells, such as 
fibroblasts or cell lines, with actual tumour cells has left us with only a rough 
approximation of the fate of cells affected by such mutations [Reya et al. 2001].   
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2.1.1. Features of cancer cells 
Cancer cells are cells affected by a series of mutations, which makes them gain 
cancerous properties. The multi-step, multi-site process of genetic alteration in 
the genome leads to the transformation of normal cells to cancerous cells 
[Hanahan and Weinberg 2000, Kinzler and Vogelstein 1996]. Even in “in vitro” 
experiments on rodent cells in culture, the transformation of cells to tumourigenic 
cells happens in at least two steps while the transformation of human cells 
requires more steps than rodents’ [Hahn et al. 1999]. In spite of the vast diversity 
in cancer sites and types, and uncertainty about the trail of mutations leading to 
tumourigenesis, Hanahan and Weinberg [Hanahan and Weinberg 2000, Hanahan 
and Weinberg 2011] have proposed six necessary changes in cell physiology to 
make the cells capable of forming malignancies: self-sufficient signalling for 
growth, insensitivity to antigrowth signals, apoptosis evasion, potency to 
unlimited replication, sustained angiogenesis, metastasis and invasion into other 
tissues. Gaining any of these features is due to the destruction of the 
corresponding opposing counterpart mechanism in cells. For instance, the 
transition of normal cells from quiescent to proliferative state is dependent on the 
existence of mitogenic growth signals. The signal receivers are a group of 
transmembrane receptors that bind to diffusive growth factors, extracellular 
matrix component, and cell-cell adhesion/interaction molecules acting as 
signalling molecules. Cancer cells are strongly independent of exogenous growth 
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stimulations and are able to generate many of the essential signals for their 
proliferation. A large body of early-discovered oncogene regulates growth 
signalling autonomy [Hanahan and Weinberg 2000].  In glioblastoma multiforme, 
one of the most malignant and common brain tumours, and sarcoma, a cancer 
initiated by mesodermal cells, the production of platelet-derived growth factor 
(PDGF) and tumour growth factor-α (TGF-A), respectively, are enablers of the 
aforementioned growth signalling autonomy [Fedi et al. 1997].  
Likewise, the cellular quiescence and tissue homeostasis in normal cells is 
maintained by several anti-growth signals such as soluble growth inhibitors and 
immobilized inhibitors in the extracellular matrix and on the surfaces of 
neighbouring cells. This anti-growth signalling can block the cell proliferation in 
two ways: first, temporally, where the cells are silent (G0 in cell cycle) till the 
extracellular matrix signalling allows them to proliferate in the future or second, 
permanently, where the cells are forced to enter the postmitotic state, that is, they 
are unable to proliferate anymore [Hanahan and Weinberg 2000]. Cancer cells are 
rendered insensitive to antigrowth signals by the disruption of retinoblastoma 
protein (pRb) and its two relatives, the p107 and p130 pathways.  In the 
hypophosphorylated state, pRb seizes and modifies the function of E2F 
transcription factors that control the expression of vital genes for the transition 
from the G1 to S phase [Hanahan and Weinberg 2000,Weinberg 1995]. Thus the 
liberation of E2F transcription factors due to pRb disruption allows the cells to 
proliferate and makes them insensitive to antigrowth signalling [Hanahan and 
Weinberg 2000, Hanahan and Weinberg 2011].  
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The life duration of cells is determined by apoptotic machinery and ruled by 
controlling the extra/intracellular (ab)normality checks that are the sensory part 
of the machinery. The effector part of apoptotic machinery consists of cell surface 
receptors that bind to death or survival factors. For example, P53 tumour 
suppressor protein is a component of apoptosis circuitry and its inactivation 
results in the formation of tumours that rarely contain apoptotic cells [Symonds et 
al. 1994, Hanahan and Weinberg 2000, Hanahan and Weinberg 2011].   
Although the three capabilities of growth self-sufficiency, insensitivity to 
antigrowth signalling and apoptosis evasion seem to be sufficient for a rapidly 
growing tumour, defunctionalisation of the cell-autonomous program that 
restricts the amount of cell replication is crucial in the formation of an aggressive 
tumour. Many studies support the observation that the majority of cancer cells 
propagated in culture have the ability of unbounded replication, suggesting that 
the tumour cells acquire this capability during the multi-step process of 
tumourigenesis and that the immortalization of cells is an essential feature of 
cancer cells [Hayflick 1997, Hanahan and Weinberg 2000, Hanahan and 
Weinberg 2011].    
During organ formation in normal conditions, the indispensible oxygen and 
nutrient requirements of cells promotes the well-coordinated growth of vessels 
(angiogenesis) and parenchyma. While cancer cells do not have the ability to 
shape the essential angiogenic bed in a normal fashion, they must undergo 
angiogenesis to be able to grow to a large size [Bouck et al. 1996, Hanahan and 
Folkman 1996, Folkman 1997]. The normal tissue encourages or blocks the 
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angiogenesis by counterbalancing positive or negative angiogenic signalling 
whereas tumour tissue is not capable of balancing positive and negative signals.  
In order to promote angiogenesis, tumour cells can relatively increase the 
angiogenesis inducing factors relative to the inhibitors [Hanahan and Folkman 
1996]. For instance, cancer cells alter gene expression to amplify the expression 
of vascular endothelial growth factors (VEGF) and/or fibroblast growth factors 
(FGF) or they may downregulate the expression of endogenous inhibitors such as 
thrombospondin-1 or beta-interferon. The upregulation of pro-angiogenic factors 
and the downregulation of anti-angiogenic ones may occur simultaneously, hence 
compounding the effect [Singh et al. 1995, Volpert et al. 1997].  
There are several proteins responsible for the adhesion of cells to their 
surroundings. These proteins (that consist of cell-cell adhesion molecules and 
link the cells to extracellular matrix substrates) are functionally altered in tumour 
tissue. For example, defunctionalisation or interference in functionality of E-
cadherin, a homotypic cell-cell interaction molecule expressed on epithelial cells, 
leads to the enhancement of invasion and metastasis [Christofori and Semb 
1995].  The pathways that normal cells take to obtain the abilities necessary to 
form malignancies are variable. The acquisition of different features of cancer 
cells may not occur in the same chronological order from one cancer to another. 
Independent of the taken steps in genetic alteration taken in order to become 
cancerous, Hanahan and Weinberg [Hanahan and Weinberg 2000] believe that 
almost all types of tumour cells share the aforementioned six features, and have 





2.1.2. Different types of cancers 
 
Cancers are classified into five major categories: carcinomas, sarcomas, leukemias, 
lymphomas and central nervous system (CNS) cancers. The intensity of cancers is 
denoted by four grades which are associated with the level of severity of tumour 
malignancy where Grade I is a benign, slow-growing tumour while cancers grouped 
in Grade IV are the most malignant. 
 
 
2.1.3. Brain cancers, different types and stages 
CNS cancers (aka brain cancers) are growing neoplasms inside the cranium or in the 
central spinal canal. Brain cancers are classified according to the exact site of the 
tumour, the type of tissue involved, whether they are noncancerous (benign) or 
cancerous (malignant). But the most important classification for brain cancers is 
associated with the origin of the preliminary cancerous cells. In the majority of brain 
cancers, tumour initiating cells are originally parts of the CNS but in some cases the 
initiating cells originate from a non-adjacent tissue or organ that causes cancer after 
invasion and metastasis into the brain. Such metastatic cancers are known as 
secondary cancers as opposed to primary cancers that have the same origin and site 
for initiating cells and tumour formation. For example, breast cancer is known to be 
a metastatic disease and often results in secondary cancers in bone, liver, lung and 
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brain [Lacroix 2006].  
The most common types of primary brain tumours are gliomas. Gliomas originate in 
glial cells, which are non-neuronal cells that provide support and protection for the 
brain neurons. Different types of glioma are named based on the histological 
similarities to specific cells, although they may not originate from that type of cell, 
for example: 
• Astrocytomas (cancer cells similar to astrocytes) 
• Oligodendroglioma (cancer cells similar to oligodendrocytes) 
• Ependymomas (cancer cells similar to ependymal cells) 




2.1.4. Particular case of GBM  
According to the World health organization (WHO) in 2007, malignant gliomas 
were classified among the most fatal brain tumours [louis et al. 2007]. Astrocytomas 
are the most common type of gliomas that develop from, star-shaped glial cells, 
astrocytes. Grade IV astrocytoma, Glioblastoma Multiforme (GBM), is one of the 
most frequent, aggressive and chemoresistant primary brain tumours, with a median 
patient survival time of 6-12 months in adults and a bleak prognosis where tumour 
recurrence is likely after surgery [Eramo et al. 2006]. Therefore, GBM has attracted 
significant media attention due to its low long-term survival rate, prevalence, 
malignancy and resistance to different therapies. This also makes it an important 





2.2. Abnormal tumour microenvironment 
Augmented and unlimited replication of cancer cells in a tissue that is not designed 
to host them normally promotes the heterogeneity of the tumour microenvironment 
and causes it to differ from the normal interstitium. In a reciprocal fashion, the 
tumour microenvironment has a profound effect on cancer cells. Some previous 
studies point to the close interaction of cell and matrix as well as cell- cell 
interactions that should be taken into account in determining cancer cell response to 
internal and external stimuli [Hill et al. 2009]. Such interactions are not restricted to 
tumorigenic tissues, but play an important and functional role in normal 
environments as well [Hill et al. 2009].  
The tumour microenvironment affects cancer cells through the endocrine, paracrine 
and autocrine signalling pathways, by means of chemicals, chemicals and physical 
forces from neighbouring cells and positive feedback signalling loops generated by 
the cancer cells themselves [Fedi et al. 1997]. Cell responses to such conditions 
include: alteration in signalling, division, differentiation, apoptosis, adhesion and 
migration.  
Among all the features of the tumour pathophysiologic microenvironment, hypoxia, 
low pH and nutrient deprivation appear to have the strongest effects on spatial and 








As the mass of solid cancer cells grows larger, the density of pre-existing normal 
vessels inside the tumour decreases. To obtain sufficient oxygen and other nutrients 
the cells must be at most 100 µm away from a blood vessel [Hanahan and Weinberg 
2000]. In normal organogenesis this distance is not exceeded since the vessels grow 
in a well-organized manner so that the necessary closeness of cells and blood vessels 
is insured. Normal cells regulate the process of new vessel formation, angiogenesis, 
inside the organ and maintain the coordinated vessel network. Cancer cells are 
initially unable to regulate a proper vessel network to keep up with the increasing 
demand of oxygen and other nutrients inside a tumour [Bouck et al. 1996, Hanahan 
and Folkman 1996, Folkman 1997]. The inability of cancer cells to generate a 
thriving mass of cells covered by coordinated vessels is due to the imbalance of 
pro/anti angiogenic factors. VEGF is the dominant growth factor involved in 
triggering angiogenesis inside the tumour. VEGF upholds the survival and 
proliferation of endothelial cells that form the inner lining of vessels. In normal 
tissues, the effect of VEGF is counterbalanced by anti-angiogenic factors such as 
thrombospondin so that new normal vessels in processes like wound healing are 
formed under a fine balance of proangiogenic and antiangiogenic growth factors.  
When VEGF signalling is upregulated abnormally, as in tumour tissues, the elevated 
amounts cause the vessels to become more permeable than normal. The aberrant 
leaky vessels have disfunctionally oversized pores and do not have the regular and 
efficient coverage for the cells they support [Jain 2008]. These deficiencies increase 
the interstitial fluid pressure (IFP) in tumour tissues. Hence, the challenges for 
tumour cells are not only oxygen and nutrient deprivation but also high pressure 
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inside the tumour due to the vessel leakage and the accumulation of tissue waste 
products.  
On one hand, the lack of sufficient oxygen content in tumours, hypoxia, and on the 
other hand, the accumulation of wastes products from defective cancer cells, 
destabilize the microenvironmental homeostasis. The tumour microenvironment is 
considerably acidic since first, in the absence of oxygen, hypoxia causes the cancer 
cells to switch to a glycolytic metabolism than the normal aerobic metabolism of 
respiration; second, the malfunctioning blood vessel network and lymph system are 
not able to clean the tumour microenvironment; and thirdly, cancer cells abnormally 
tend to utilize other metabolisms than respiration even in the presence of sufficient 
oxygen.      
The formation of new blood vessels is a result of either the pre-existing vessels 
sprouting into the tumour, generally known as angiogenesis, or vessel assembly 
from endothelial precursors, vasculogenesis. Although vasculogenesis was 
considered to be restricted to embryonic development for a long time, recent studies 
have demonstrated that some of the endothelial cells inside the tumour are more 
similar to tumour cells than to pre-existing endothelial cells in terms of somatic 
mutations [Wang et al. 2010, Ricci-Vitiani et al. 2010].  In GBM, one of the most 
angiogenic malignancies, a subpopulation of cancer cells strongly promotes 
angiogenesis through the release of VEGF and stromal-derived factor1. These minor 
but functionally dominant cancer cells have the same genomic alteration as 20-90% 
(mean 60.7%) of tumour endothelial cells [Ricci-Vitiani et al. 2010]. This finding 
suggests that typically more than half of the GBM endothelial cells have their origin 
in the neoplasm.    
Atypical blood and lymph circulation is the golden link in the chain of tumour 
microenvironment abnormalities. Except for the innate tendency of cancer cells to 
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switch to other metabolisms than respiration, all other key features of the tumour 
microenvironment, such as high IFP, hypoxia and acidity are clear results of the 
tangle of dysfunctional vessels.  
In spite of many antiangiogenic methods that cause the destruction of the 
vasculature inside the tumour, some methods aim to normalize them instead. In 
these methods the delivery of chemotherapeutic agents is the final goal and is 
achieved by balancing anti and proangiogenic factors that lost their equilibrium 




The state of low levels of oxygen, hypoxia, is perhaps the most important feature of 
the tumour microenvironment. The fluctuation of oxygen concentration in the 
tumour microenvironment is the outcome of irregular blood flow, poor oxygen 
diffusion across the tumour and the chaotic vascular network within the tumour 
[Heddleston et al. 2010]. Severe hypoxia may result in upregulation of pro-apoptotic 
pathways and consequently cell death; genotoxic effects are the outcome of 
prolonged hypoxia and are caused by the induction of reactive oxygen species 
(ROS) [Heddleston et al. 2010]. The commonly observed necrotic tumour core is the 
mass of dead cells that could not survive the hypoxic conditions. Hypoxia may also 
have other extensive transcriptional effects, for instance the activation of pro-
angiogenic pathways.  
Persistence of the hypoxic condition inside the tumour tissue leads to the induction 
of hypoxia inducible factors (HIFs). The activity of HIF proteins boosts the tumour 
progression through the upregulation of angiogenesis, alteration of cellular 
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metabolism and invasion [Hill et al. 2009, Heddleston et al. 2010, Keith and Simon 
2007, Seidel et al. 2010, Bao et al. 2009,  Heddleston et al. 2009, McCord et al. 
2009, Li and Rich 2010].  
HIF transcription factors are generally categorized into two subunits, α and β, each 
having three members (HIF-1α, HIF-2α, HIF-3α, and HIF-1β, HIF-2β, HIF-3β). The 
constantly expressed beta subunits are insensitive to oxygen and act as receptors for 
their α counterparts [Liao and Johnson 2007]. In normoxic conditions, the activity of 
HIF-α is decreased by prolyl hydroxylases (PHDs) that bind to Von Hippel Lindau 
proteins for final degradation of HIF-α via ubiquitin-proteasome pathways [Hill et 
al. 2009, Berra et al. 2003, Semenza 2004]. In the absence of an adequate level of 
oxygen, the reduction of oxygen-dependent activity of PHDs increases the 
unsuppressed expression of HIF-α [Semenza 2004]. 
Hypoxia inside the tumour varies spatially and temporarily [Heddleston et al. 2010]. 
Due to the aberrant blood flow and abnormal vascular structure, hypoxic cycles are 
more considerable in microvasculature regions [Kimura et al. 1996]. The fluctuation 
of oxygen content causes the alteration of HIF activity. The importance of 
identifying hypoxic regions is not only limited to the prominent effect of hypoxia in 
promoting angiogenesis, proliferation and tumour invasion but also extends to the 
radio-resistance of hypoxic regions [Moeller et al. 2004, Dewhirst et al. 2008].  
HIFα is a key regulator that triggers angiogenesis through direct activation of 
vascular endothelial growth factors [Forsythe et al. 1996, Olsson et al. 2006]. 
Therefore, HIFα plays a critical role in tumour angiogenesis since the tumour 
vascular network is known to be strongly dependent on VEGF-recruiting pathways. 
VEGFs are cell surface bound proteins that promote proliferation, migration and 
survival of endothelial cells by binding to the specific high affinity transmembrane 
proteins on endothelial cells [Bao et al. 2006]. In order to form new vasculature 
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inside the tumour, VEGF promotes the activity of endothelial precursors. 
Besides the probable promoted genetic mutations, the upregulation of HIF under 
low oxygen tension can also affect cell differentiation. In some cancer studies, the 
origin of the majority of endothelial cells has been shown to be cancer cells. These 
studies demonstrate that the differentiation of non-endothelial CD133+ cancer cells 
to endothelial cells is highly positive-correlated with the intensity of hypoxia in a 
tumour [Wang et al. 2010, Ricci-Vitiani et al. 2010]. Some other studies have 
demonstrated that hypoxic conditions enhance genetic mutations, which elevate the 
pluripotency of cancer cells and lead to more malignant tumours [Seidel et al. 2010, 
Bao et al. 2009, Heddleston et al. 2009, McCord et al. 2009, Li and Rich 2010, 
McLendon and Rich 2011]. 
 
2.2.3. Acidity 
The acidity of the tumour microenvironment is a result of abnormalities in the 
microenvironment and cancer cell characteristics. Hypoxia, as a common feature of 
the tumour microenvironment, blocks the process of respiration for cells. Although 
respiration, as the first potential choice of normal cells, is the most efficient cell 
metabolism to satisfy cell energy requirements (ATP), cancer cells may switch to 
other metabolisms such as glycolysis and glutaminolysis to survive in hypoxic 
conditions. Cancer cells may preferentially select a glycolytic metabolism even in 
the presence of sufficient oxygen for respiration. In this situation, called the Warburg 
effect or aerobic glycolysis, the produced ATP is one eighteenth of the energy 
provided by the oxidation of one molecule of glucose in the respiration reaction. 
Grüning and Ralser [Grüning NM, Ralser M. 2011] have very recently proposed that 
the reason behind the tendency of cancer cells to glycolysis rather than respiration is 
to avoid the accumulation of reactive oxygen species that cause oxidative damage. 
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Hence, the uptake of glucose to generate the energy through glycolysis is more than 
the amount of glucose uptake in respiration. However, the main problem of having 
glycolysis rather than respiration in cancer tissues is the accumulation of products of 
glycolysis reaction such as hydrogen ions. Impairments in the glycolytic pathway 
result in cancer cells switching to a glutaminolytic metabolism [Helmlinger et al. 
2002]. In healthy tissues, neutrality is maintained through the balanced contributions 
of vascular and lymphatic systems in supplying nutrient and collecting waste and 
also the involvement of the natural buffering systems. The most prominent buffering 
reaction is the interconvertion of bicarbonate and carbon dioxide. However, the 
aberrant structure of the vasculature and lymph inside the tumour tissue, and the 
excess accumulation of waste products, especially hydrogen ions, makes the tumour 
microenvironment acidic. 
Similar to hypoxia, high acidity of the tumour microenvironment has been observed 
to affect cancer cell reprogramming and worsen tumour malignancies [Hjelmeland 
et al. 2011]. The immune system, as the first natural guard against abnormal cancer 
cells that survive the internal protection paths, is paralyzed in an acidic 
microenvironment. The situation is even worse, since hypoxia and acidity are both 
ubiquitous in cancer tumours. Although the spatiotemporal profiles of hypoxia and 
acidity are not fully correlated [Helmlinger et al. 1997], they are both critical 
features of the tumour microenvironment and play dominant roles in the progression 
of tumour malignancies.     
The partial pressure of oxygen, which is inversely related to the level of hypoxia, 
strongly correlates with pH in tumour microenvironment on average. However the 
heterogeneities between partial pressure of oxygen (pO2) and interstitial pH profiles 
and incompatible relation between local pO2 and pH profile have been reported in 
some “in vivo” experiments [Helmlinger et al. 1997].  
In spite of the aforementioned relationship between of pH and hypoxia, these two 
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prominent microenvironmental factors seem to act independently to promote 
vascular endothelial growth factors [Fukumura et al. 2001]. In vivo experiments 
done by Fukumura et al. support the autonomous role of acidity and hypoxia in 
VEGF up-regulation [Fukumura et al. 2001]. Their study, focused on brain cancers, 
proposing that although the effect of acidity and hypoxia are not correlated on 
VEGF promotion, there is no additive effect of both in regions exposed to hypoxia 
and acidity simultaneously. An explanation for this non-additive effect may be the 
fatal consequences of the coincidence of hypoxia and acidity that causes apoptosis 
[Fukumura et al. 2001]. Casciari et al. in their 1992 experiments have confirmed the 
results of Fukumura et al. [Casciari et al. 1992]. Their experiment investigated cell 
growth rates and metabolism under different oxygen and glucose concentrations and 
extracellular pH. They state that cell growth rates in regions exposed to hypoxia and 
acidity simultaneously is less than that when exposed to only one of hypoxia or high 
acidity.   
 
 
2.2.4. High interstitial fluid pressure 
Mainly due to abnormal angiogenesis, IFP is highly elevated in solid tumours. Other 
factors involved in elevation of IFP are lymph vessel abnormalities, interstitial 
fibrosis and the contraction of the interstitial matrix mediated by stromal fibroblasts 
[Heldin et al. 2004].  The elevated level of IFP in tumours opposes the transcapillary 
oxygen and nutrient transport and waste collection that makes the situation bleak for 
cancer cells. However, a major concern about high IFP is the resulting decreased 
efficiency in therapeutic agent uptake. Some methods have been introduced in order 
to improve therapeutic agent uptake, for instance, Heldin et al. proposed the usage 
of signal-transduction antagonists to lower IFP [Heldin et al. 2004]. However, 
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considering the chaotic and dysfunctional vasculature inside the tumour, it is hard to 
maintain the IFP at normal levels. 
 
2.3. Brain cancer stem cell hypothesis 
2.3.1. Stem cells and cancer stem cells hypothesis 
 
There are many different types of standard treatments designed to stop tumour 
growth, but the overwhelmingly frequent failures of these conventional procedures 
have revealed that the current knowledge (about tumour growth dynamics, the 
interaction of cancer cells with the tumour microenvironment and the disruptive 
mechanism of therapeutic agents) is not comprehensive enough. One source of the 
complexity of tumour development and growth is tumour heterogeneity. These 
heterogeneities are the result of on-going mutagenesis and/or the differentiation of 
cancer cells [Reya et al. 2001]. The expression of some differentiation markers by 
tumour tissues supports the cancer cell differentiation argument [Reya et al. 2001]. 
The diverse clusters of cancer cells inside the heterogeneous tumour do not only 
differ in phenotype and differentiation state, but also in proliferative potential and 
ability to increase tumour progression. For the first time, some evidence in 
leukaemia and more recently in solid tumours, such as breast cancers, supports the 
distinct functionality of different subpopulations of cancer cells [Singh et al. 2004]. 
This evidence suggests that there may be a small subpopulation of cancer cells 
capable of tumour initiation, tumour maintenance, and differentiation to some other 
progenies [Reya et al. 2001, Singh et al. 2003, Singh et al. 2004, Dirks 2008]. The 
existence of such a subpopulation of cancer cells is proposed in the “cancer stem cell 
hypothesis”. According to the cancer stem cell hypothesis, although this 
subpopulation is a small fraction of tumour cells, it is the dominant factor in the 
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progression of a tumour malignancy and is known to be both necessary and 
sufficient to maintain tumours. Due to the four basic similarities they share with 
normal stem cells [Fuchs and Segre 2000, Weissman 2000, Reya et al. 2001], they 
are known as “cancer stem cells”. In analogy with normal stem cells, cancer stem 
cells (CSC) are able to differentiate to other cell types, they can self renew through 
symmetric division, they are capable of forming colonies, and they express the same 
surface markers as normal stem cells. They are also comparable with normal stem 
cells in the size of the population, as many studies have reported that the population 
of cancer stem cells is 5-15% of the bulk of tumour cells [Dirks 2008, Chaffer et al. 
2011].  
 
2.3.2. CD133  
Beside the functional similarities between normal and cancer stem cells, they also 
have some physiological resemblances; for instance, some of the well-known 
biomarkers to target normal neural stem cells are also expressed by neural cancer 
stem cells. Nestin, a cytoplasmic intermediate filament protein, is expressed by 
normal and cancerous stem cells [Hockfield and McKay 1985, Lendahl et al. 1990, 
Gates et al. 1995]. But nestin is not a perfect marker for normal or cancer stem cells 
since the neural progenitors do express nestin as well. Therefore, in spite of the 
similar identity of normal and cancer stem cells biomarkers, the absence of reliable 
biomarkers for normal neural stem cells clouds the issue of identification of neural 
cancer stem cells. 
Lately, direct isolation of normal neural stem cells from human foetal brain 
suggested that the cell surface marker CD133 (AC 133, prominin1) could be a good 
candidate to target normal and cancerous neural stem cells [Singh et al. 2004, Singh 
et al. 2003]. Singh et al. (2003) reported that after fractionation and purification of 
brain cancer cells which CD133+ expression, they found that like normal stem cells, 
this minor subtype of neural cancer cells are capable of proliferation, differentiation 
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and self renewal. Despite these analogous functional characteristics, normal and 
cancer neural stem cells express nestin and CD133+, while none of them express the 
neural differentiation markers [Singh et al. 2003, Singh et al. 2004].   
 
 
2.4. Cancer stem cells and tumour microenvironment 
The condition of the tumour microenvironment that is determined by the level of 
hypoxia, acidity, IFP, nutrient concentration, and generally extracellular matrix 
composition, accompanied by the distribution of different cell types in the 
heterogeneous tumour strongly affect the stem cell fate to self-renew or to 
differentiate [Moore and Lemishka 2006]. The dependence of cancer stem cells’ fate 
(self renewal or differentiation) to tumour microenvironmental factors is even higher 
than normal stem cells since the intrinsic and extrinsic cellular mechanisms are all 
exaggerated inside the aberrant structure of tumours. Therefore, based on the 
specific constellation of microenvironmental factors, the tumour region is 
partitioned into sub-regions which each upregulates specific features of cancer cells; 
one may promote the self- renewal of cancer cells while others may suppress it 
[Calabrese et al. 2007, Gilbertson and Rich 2007, Jandial et al. 2008]. 
 
 
2.4.1. Cancer stem cells and vascular niches 
Normal stem cells quiescence, self-renewal and differentiation are controlled by 
microenvironmental factors. Protective niches that normal stem cells lie in, suppress 
the excessive proliferation and differentiation of stem cells and keep them quiescent 
[Calabrese et al. 2007, Moore and Lemishka 2006]. Nonetheless, inside tumour 
tissues, the critically abnormal microenvironment and mature types of neighbouring 
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cells are not able to suppress the cancer stem cells’ self-renewal. The perivascular 
niches are known to be one of the self-renewal promoting niches for BCSCs 
[Calabrese et al. 2007]. The endothelial cells are well recognized to dominantly 
affect BCSCs and secrete factors that promote self-renewal rather than quiescence or 
differentiation. Endothelial cells that closely interact with cancer stem cells 
encourage self-renewal through the secretion of supporting factors [Calabrese et al. 
2007]. On the other hand, cancer stem cells upregulate the process of angiogenesis 
through the secretion and recruitment of pro-angiogenic factors such as VEGF, 
VEGFR2, angiopoietin 2, and stromal derived factor 1 [Bao et al. 2006, Calabrese et 
al. 2007, Gilbertson and Rich 2007, Folkins et al. 2009, Lathia et al. 2010]. This 
reciprocal interaction of cancer stem cells and the tumour microenvironment results 
in the formation of perivascular niches to host cancer stem cells that seem to mimic 
normal stem cell niches in healthy tissues [Calabrese et al. 2007, Gilbertson and 
Rich 2007, Jandial et al. 2008].  
The effectiveness of anti-angiogenic therapies for GBM patients suggests that 
angiogenesis and a vascular bed are indispensible features to maintain GBM 
[Aghajanian et al. 2011,Batchelor et al. 2007]. The interesting fact is the use of anti-
angiogenic therapies does not affect the proliferation and survival of nonstem cancer 
cells and the improvements are due to blocking the growth of the tumour via 
depleting the vasculature from the cancer stem cells niches [Gilbertson and Rich 
2007].    
In spite of the ability of GBM cancer stem cells to upregulate angiogenesis, recent 
studies have revealed the contribution of vasculogenesis in GBM tumours [Wang et 
al. 2010,Ricci-Vitiani et al. 2010]. According to Vitiani et al. and Wang et al. (2010), 
phenotypic similarities between cancer stem cells and almost half of tumour 
endothelial cells suggest the cancerous origin of endothelial cells. They have 
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suggested that together with vasculature formation by sprouting of pre-existing 
vessels through angiogenesis, the differentiation of cancer stem cells to endothelial 
cells produces a large proportion of the GBM vascular network [Wang et al. 2010, 
Ricci-Vitiani et al. 2010]. The ratio of endothelial cells that have the same genomic 
alteration as the GBM cancer stem cells is reported to vary from 20% to 90% (Mean 
60%) of total endothelial cells inside the tumour [Ricci-Vitiani et al. 2010].  
The vital importance of cancer stem cells existence in tumour maintenance, the 
reciprocal impact of vasculature network on cancer stem cells and the partial 
effectiveness of anti-angiogenic therapies in malignancies such as GBM highlights 
the necessity of more research in this field.  
 
2.4.2. Cancer stem cells and hypoxia 
The spatiotemporal fluctuation of oxygen inside the tumour causes transcriptional 
activity of hypoxia inducible factors that respond to hypoxia through pro-angiogenic 
or pro-glycolytic pathways [Heddleston et al. 2010]. Hypoxia increases the number 
of cells expressing CD133, known as a marker for BCSC, in gliomas [Platet et al. 
2007].  
In contrast with HIF-1α that is a hypoxia inducible factor expressed by stem and 
non-stem cancer cells, HIF- 2α is only expressed by cancer stem cells [Bao et al. 
2009]. The poor survival of GBM patients is negatively correlated with the 
expression of HIF-2α inside the tumour. The mechanism that HIF-2α uses to 
provoke angiogenesis, the same as HIF-1α, is through the increase of the expression 
of VEGF [Bao et al. 2009, Bao et al. 2006]. However, the increase in VEGF 
expression has been shown to occur in a cell-specific manner so that the VEGF 
expression induced by hypoxia in BCSCs is higher than the level of VEGF 
expressed in non-stem cancer cells exposed to the same level of hypoxia [Bao et al. 
2009]. 
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In a related study, Heddleston et al. (2009) proposed that hypoxia promotes the self-
renewing capacity of cancer stem cells and upregulates the reprogramming of non-
stem cancer cells toward a stem-like phenotype [Heddleston et al. 2009]. The 
promotion of stem-like phenotypes by hypoxia functionally leads to increased 
neurosphere formation and biologically results in the upregulation of stem cell 
factors such as OCT4, NANOG and c-MYC [Heddleston et al. 2009].  
Seidel and colleagues reported the same results with a focus on the role of HIF-2α 
[Seidel et al. 2010]. First, they hypothesized that HIF-2α plays a significant role in 
inducing the stem-like phenotype in the hypoxic region of GBM tumours. To test 
this hypothesis, they knocked down HIF-2α and observed the reduced inducement of 
the stem-like phenotype due to hypoxia [Seidel et al. 2010].     
Another difference between HIF-1α and HIF-2α is their sensitivity to hypoxia. HIF-
1α, which is associated to both stem and non-stem cancer cells, is only activated in 
severe hypoxic condition (when the oxygen level is less than 1%); whereas HIF-2α 
associated with stem cells, is expressed in less severe levels of hypoxia (when the 
oxygen concentration is 2% to 5%) [Bao et al. 2009]. The relevance of such an 
affiliation of hypoxia inducible factors has been confirmed by some other studies 
[Seidel et al. 2010].   
Suggesting the necessity of the presence of at least one cancer stem cell for active 
metastatic growth, Hill et al. (2009) have provided a more detailed view of the effect 
of hypoxia on metastasis [Hill et al. 2009]. Under hypoxic conditions, cancer stem 
cells start to respond to the oxygen shortage through the transcriptional factors, HIF-
1α and HIF-2α which each has a different role in tumour progression. HIF-1α 
promotes the undifferentiated state of cancer stem cells through the upregulation of 
Notch signalling. HIF-1α is also known to upregulate motility, invasion and 
metastasis through the elevation of CXCR4 (specific receptor for stromal derived 
factor-1), MMPs (matrix metalloproteinases), uPAR (urokinase receptor), and 
VEGF. Equally important, HIF-2α controls the cancer stem cell maintenance 
through the induction of Oct-4 (octamer-binding transcription factor 4) and also 
increases cancer stem cell proliferation by activating c-MYC [Hill et al. 2009].  
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Hence, hypoxia generally influences cancer stem cells in proliferation, self-renewal, 
differentiation, motility, invasion and metastasis and affects the tumour 
microenvironment by the promotion of angiogenesis and vasculogenesis.  
 
 
2.4.3. Cancer stem cells and acidity 
The tumour microenvironment acidity is due to abnormalities in the 
microenvironment and the characteristics of cancer cells. Hypoxia, as a common 
feature of the tumour microenvironment, inhibits the process of respiration for cells 
and also upregulates the glycolytic pathways. Accompanied by the abnormal 
tendency of cancer cells to switch to glycolysis rather than respiration (Warburg 
effect), the inefficiency of the natural buffering system in responding to the 
accumulated amount of hydrogen ions due to the aberrant vascular and lymphatic 
systems, results in an acidic microenvironment inside solid tumours.  
Despite the prominent effect of high acidity on cancer cells, cancer stem cells are 
also reciprocally influenced by the high acidity of the tumour microenvironment. In 
their recent study, Hjelmeland et al.  (2011) have proposed that the exposure to low 
pH of glioma cells leads to the enhancement of stem-like biological and functional 
properties of the cancer cells. Independent of hypoxia, acidity promotes the 
expression of pluripotency markers that are normally expressed by neural stem cells 
such as Olig2, Oct4 and Nanog. The increase in expression of these markers in the 
low pH range is from six to eight fold higher than under normal pH conditions. On 
the other hand, the expression of differentiation markers under acidic conditions is 
noticeably decreased. In addition to the biological effect, low pH promotes 
neurosphere formation and tumorigenic capacity of glioma stem cells. Neurospheres 
are non-adherent and free floating spherical structures generated by neural stem 
cells. 
Moreover, high acidity upregulates angiogenesis through the increased induction of 
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VEGF. The expression of HIF-2α, as a hypoxia-inducible factor associated with 
cancer stem cells, is increased noticeably, while there is no significant change in the 
expression levels of HIF-1α under the exposure of low pH [Hjelmeland et al. 2011].  
 
 
2.5. Summary  
Cancer stem cells are believed to be the predominant factors driving tumour 
progression and strongly correlate with tumour malignancies. Therefore, the 
dependence of cancer stem cell behaviour on the microenvironment highlights the 
importance of developing both a comprehensive spatiotemporal map of the tumour 
microenvironmental factors (nutrients concentration, pH and IFP) and a deeper 




















GBM is the most common brain tumour found in adults. GBM is also the most 
aggressive type of primary brain tumour with a very poor prognosis and low long-
term survival rates. Regardless of their age, most patients with GBM die in less than 
one year. The dominant role of GBM cancer stem cells to boost neurosphere 
formation, cancer invasion and metastasis, beside their prominence as a potential 
source of vasculogenesis along with angiogenesis in tumour tangled vascularisation 
highlights the importance of in-depth studies about BCSC dynamics. 
Tumour microenvironmental factors such as hypoxia, acidity, and the abnormal 
vascular network highly influence the fate of stem and non-stem cancer cells to 
become quiescent, proliferating, differentiating or reprogramming toward a stem-
like phenotype. In addition, the efficiency of the therapy is highly dependent on the 
tumour microenvironmental conditions and the state of BCSC.  
The interaction of cancer cells and tumour microenvironmental factors is highly 
complex and not well investigated. On the other hand, animal or in vitro studies are 
not accurate enough and suffer from lack of correlation with human data. Along with 
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aforementioned issues, the low survival rates and the excessive cost of using 
ineffective therapies necessitate the development of mathematical models and 
computer simulations to model tumour growth.   
The advantages of in silico modeling of cancer growth is that one can control 
variables such as different types of cancer cells and the various microenvironmental 
factors simultaneously to simplify the complex interaction map between the 
involved variables. Also, the order of importance among the affecting factors can be 
revealed through systematic approaches utilizing the mathematical and 
computational models. This is analogous to biological experiments with various 
genetically modified mice. Moreover, the merit of mathematical and statistical tools 
to analyze biological data and make testable hypotheses must not be underestimated 
[Kam et al. 2012].  
    
 
 
3.1. General models for cancer growth 
The proposed models for tumour growth, invasion and metastasis can be divided 
into three broad categories: continuum, discrete and hybrid models. In continuum 
models, a cancer tumour is considered to be a continuous porous solid comprised of 
cancer cells where the pores are filled with interstitial fluid. In contrast, discrete 
models are focused on the individual cancer cell and its contributions towards` 
tumour survival and progression. These agent-based (cell-based) models are 
conventionally classified with respect to the incorporation of cell structure details in 
the model; the model may consider the cells as nuclei-centered species or 
deformable structures [Preziosi  2003, Araujo and McElwain 2004, Anderson et al. 
2007, Byrne and Drasdo 2009, Lowengrub et al. 2010, , Rejniak and McCawley 
2010, Rejniak et al 2010, Rejniak and Anderson 2011].  
The complex interactions between cancer cells and the tumour microenvironment 
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over different time and space scales necessitate the combination of continuum and 
discrete models. Hybrid models, mixtures of continuum and discrete models, can 
provide insights which can not be obtained using either method alone. Hybrid 
models benefit from the agent-based setup of discrete models to model the cell-cell, 
cell-ECM interactions and take advantage of continuous methods to model the 
integrated tumour tissue [Rejniak and Anderson 2010].   
 
 
3.1.1. Previous work 
Tumour proliferative growth and invasion have been widely studied through 
theoretical and computational modeling [Perumpanani and Sherratt 1996, Sherratt 
and Nowak 1992, Tracqui 1995]. Duchting and Vogelsaenger were among of the 
pioneers of computational-mathematical modeling of tumour proliferation. They 
proposed a three-dimensional cellular automaton on a cubic lattice to model the 
growth of small tumours. The model considered the cells’ requirements for nutrition 
but not cell-cell interaction or other microenvironmental factors [Duchting and 
Vogelsaenger 1985].   
Afterwards, Qi and colleagues (1993) reproduced Gompertzian results for tumour 
proliferation. They used a two-dimensional cellular automaton where only those 
cells with empty neighbours were able to divide. The inability of cancer cells to 
push aside neighbouring cells in order to make space for their division weakened the 
ability of their model to satisfy biological constraints and restricted the simulated 
tumour size to very small size. They also considered the dissolution of dead cells as 
a result the models could not generate the necrotic cores of tumours. The transition 
switches from quiescent to proliferative states were chosen stochastically however, 
as considered in Duchting and Vogelsaenger’s model, the role of nutrition to turn on 
and off the division cycles is not negligible [Duchting and Vogelsaenger 1985, Qi et 
al. 1993].   
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The concepts of cancer cell migration and macroscopic behaviour patterns of cancer 
cells affected by growth factors have been introduced more recently by Smolle and 
Stettner [Smolle and Stettner 1993]. Duchting and Vogelsaenger, they considered a 
cubic lattice. Although the cubic or square lattices simplify the study of automata 
organization, the resultant asymmetric and other artificial lattice effects are not 
desired [Duchting and Vogelsaenger 1985].  
For example, modeling of macroscopic tumour growth can be found in the work of 
Wasserman and colleagues (1996). They applied the finite element technique to 
model the macroscopic behaviour of cancer tumour. Chaplain and Sleeman also 
used an analogous methodology to construct a model governed by a strain-energy 
function according to nonlinear elasticity theory [Chaplain and Sleeman 1993].  
Gompertz models have also been used extensively in tumour growth modeling. 
These models describe the evolution of tumour volume over time. The tumour 
growth rate is considered to be exponential at first and gets saturated at large times 
[Steel 1997].  These models have been criticized for the fact that tumours may 
contain a number of clones with different growth rates and different nutritional 
needs, but the Gompertz model cannot incorporate these diversities [Duchting and 
Vogelsaenger 1985].  
To add the competitive effect of multi-clonal tumours, Cruywagen and colleagues 
proposed the Jansson-Revesz equation. This equation assumes logistic growth 
(Lotka-Volterra equation) of tumours equipped with the possibility of conversion of 
one species to another. They also added a diffusive term to each Jansson-Revesz 
equation to compensate for the biological passive cellular motion [Cruywagen et al. 
1995]. In spite of the ability of these models to describe the general size of the 
tumour, the lack of cellular motility and inability to expand the modeling to multiple 
populations beyond two, is a severe limitation [Marusic et al. 1994].    
To model the growth of the tumour necrotic core, the continuum mechanics 
approach has been widely used. In such models, spatiotemporal differential 
equations are used to describe the necrosis growth. For instance, Adam (1986) used 
an ordinary differential equation and a reaction-diffusion equation to reflect the mass 
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conservation of tumour cells and nutrient diffusion respectively [Adam 1986]. A 
comparable approach was used by Ward and King (1997). They formed a system of 
nonlinear partial differential equations to describe the growth of an avascular tumour 
and nutrients diffusion within the tumour [Ward and King 1997]. More recently, 
Byrne and Chaplain (1998) improved Ward and King’s model by adding the explicit 
effects of apoptosis and necrosis [Byrne and Chaplain 1998].  
The selection of the type and intensity of therapy to treat the cancer has a major 
effect on the growth trends of tumours. There are some notable models that consider 
the impact of therapy on tumour growth, among these, work done by Tracqui and 
colleagues (1995) and Woodward and colleagues (1996) are noteworthy [Tracqui et 
al. 1995, Woodward et al. 1996].  
 
 
3.1.2. Stem cell growth models 
 Cancer stem cells, like their normal counterparts, are able to divide symmetrically 
or asymmetrically. Through the symmetrical process, cancer stem cells divide into 
two progenitors (full-differentiation) or two cancer stem cells (full-self-renewal). 
The asymmetric process ends in the birth of one cancerous progenitor and one 








Where S denotes a cancer stem cell and P is a progenitor. Progenitors are more 
mature cells with the potential for a restricted number of divisions as opposed to the 
limitless capability of cancer stem cells for symmetric and asymmetric divisions. 
The recent mathematical model of Boman and colleagues supports the hypothesis 
that the self-renewal of cancer stem cells is largely responsible for the  formation of 
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the overpopulated cancerous clones found in colorectal cancer [Boman et al. 1997]. 
Wichmann and Loeffler have proposed a cancer stem cells hierarchical model for the 
hematopoietic system [Wichmann and Loeffler 1985].  Michor and colleagues have 
added treatment analysis to the hierarchical model of cancer stem cells as have 
Johnson et al. for chronic myeloid leukemia and colorectal cancer respectively 
[Michor et al. 2005, Johnston et al. 2007]. In the case of gliomas, the proposed 
continuous models by Swanson and colleagues [Swanson et al. 2008] and Stein et al. 
[Stein et al. 2007] are remarkable examples. Swanson et al. do not consider the 
cancer stem cell hypothesis but base their model on a microenvironmental 
heterogeneous bed for a homogenous population of brain cancer cells. Stein and 
colleagues, distinguished two subpopulations of brain cancer cells, are in the tumour 
core and the often more invasive cancer cells in tumour margins. Improving the 
Wichmann and Loeffler’s model, Ganguly and Puri [Ganguly and Puri 2006, 2007] 
pioneered the application of the cancer stem cell hypothesis to model gliomas.  
To illustrate the mechanisms behind brain tumour growth, our group has recently 
proposed a stochastic discrete model [Turner et al. 2009]. The assumed stochasticity 
not only matches the observed biological phenomena, but also makes the model 
applicable when working with small numbers of cells [Turner et al. 2009, Clayton et 
al. 2007]. This model aims to characterize brain tumours and predict the 
effectiveness of potential therapies. According to our previous model, the 
classification of cancer cells into stem and non-stem cancer cells is of major 
importance since the presence of cancer stem cells is the dominant factor in tumour 
growth and progression. Moreover, the incidence of self-renewal division rather than 
full-differentiation of cancer stem cells make the tumours more resistant to therapies 
and increase the survival rates of tumour [Turner et al. 2009].   
Recent studies of tumour microenvironmental factors and their interactions with 
cancer cells in tumour progression have revealed that non-stem cancer cells can 
dedifferentiate into stem-like cancer cells [Wang et al. 2010, Ricci-Vitiani et al. 
2010, Seidel et al. 2010, Bao et al. 2009, Heddleston et al. 2009, Hjelmeland et al. 
2011, Chaffer et al. 2011, Denysenko et al. 2010]. The new cells produced through 
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cell reprograming are able to form neurospheres and also express the biomarkers of 
normal stem cells. The functional and biological features of these stem-like cancer 
cells assert their abilities to form neurospheres as well as the expression of stem cell 
surface markers. This data proves compelling evidence that the tumour 
microenvironment can promote the stem cell even in the initial absence of cancer 
stem cells depleted culture.   
 
 
3.2. Model Foundation and assumptions 
The current model is based on the model proposed by Turner et al. [Turner et al. 
2009]. In the previous model, two basic subpopulations of cancer cells were 
assumed: cancer stem cells and progenitors. Hence the symmetric and asymmetric 









the first three division pathways are cancer stem cells pathways and the last two are 
for progenitors. The first pathway denotes the symmetric division of cancer stem 
cells, self-renewal, and the third represents the symmetric full-differentiation. The 
second, asymmetric pathway of cancer stem cell division is known to have a slightly 
more of an effect on tumour malignancies compared with the first. The fourth 
pathway shows the division of a progenitor. As opposed to stem cells, progenitor 
replications are limited hence their division process will terminate at some point. 
While the last pathway denoting the progenitor dedifferentiation confers immortality 
to the bulk of cancer progenitor cells. The existence of the last pathway has been 
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reported by Chaffer et al. [Chaffer et al. 2011]. In their recent work, Weinberg and 
colleagues [Chaffer et al. 2011] have challenged the conventional hierarchical model 
of the cancer stem cells. Their experimental results go against the traditional view of 
unidirectional differentiation of cancer cells. Instead they have proposed a 
bidirectional interconversion between cancer stem cells and non-stem cancer cells. 
Focusing on the human mammary epithelial cells in breast cancer, they have also 
reported the spontaneous reprograming of more differentiated cell types, 
progenitors, to stem-like cancer cells. Hence, as mentioned in the last division 
pathway, progenitors may transform to stem cells or at least to a progenitor from a 
different phenotype explicitly rather than through division [Chaffer et al. 2011]. 
According to the reported gradual increase in fraction and saturation of cancer stem 
cells and progenitors in their model, we have assumed 8 different phenotypes of 
cancer cells from a stem cell phenotype as the first, and fully mature cancer cells 
that are enabled to replicate. Considering this assumption, division pathways for the 
first phenotype, a cancer stem cell, can be rewritten as below: 
 
                                                           S→S+S 
S→S+P1  
S→ P1 +P1 
 
Herein, P1 is a progenitor with the most similarities with cancer stem cells while the 
next generation of progenitors, P2, differs more from a cancer stem cell than a P1 
phenotype. The P1 division and dedifferentiation pathways are: 
 
P1 → P2 +P2  
P1 → S 
Following the same procedure for other phenotypes of progenitors (we assumed we 
have seven different types of these) we form the following division and 
dedifferentiation pathways:  
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P2 → P3 +P3  
P2 → P1  
P3 → P4 +P4 
P3 → P2  
P4 → P5 +P5 
P4 → P3  
P5 → P6 +P6  
P5 → P4  
P6 →M +M  
P6 → P5 
M → ∅  
 
where M denotes the most mature cell type inside the tumour. M cells are not able to 
replicate through division, but they may die in response to the tough and fatal 
conditions in the tumour microenvironment.   
The division format for progenitors, dictates their limited ability to replicate; each Pi 
divides into two progenitors Pi+1. Thus, through the introduced pathways we assume 
the replication ability of progenitors to be restricted to at most 6 times, of course 
except for the dedifferentiation detours of progenitors.  
Beside the assumption of sudden switching of progenitors to less differentiated 
phenotypes and gradual differentiation and dedifferentiation of cancer stem cells and 
progenitors respectively, we made another assumption on the rate of division and 
dedifferentiation pathways. Here after, we suppose that the division rates for all 
types of progenitors are the same. We assumed the same argument for the 
differentiation rate of progenitors so that the division rate of all Pi  (i=1:6) is 
identical (will be denoted by ρP  afterwards) and so the dedifferentiation rate (will 
be represented by γ ).  
Following Turner et al. (2009), we also assumed that the death rate of an M cell is 
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zero. This is a valid assumption in short time scales (see the experimental data 
presented in the next section). However the possibility of each cancer stem cell 
division incidence as a determining factor of tumour survival is distinct from others. 






S → S+S 
S
r2*ρS → S+P1  
S
r3*ρS → P1 +P1 
for i=1 to 6 
Pi
ρP → Pi+1 +Pi+1 
Pi
γ → Pi−1 
where P7  is M and 
M Γ≈0 → ∅     
 
Our last assumption in constructing the model is that the cell divisions are 
stochastic. We considered that the selection of the self-renewal, division, 
differentiation and dedifferentiation of cancer cells has a random component. The 
existence of the random compartment is supported by the work of Till and 
McCulloch for hematopoietic stem cells [Till et al. 1964]. Till and colleagues [Till et 
al. 1964] and Clayton et al. [Clayton et al. 2007] have also assumed that the process 
of cancer cell division is a Markovian process. The Markovian property of a process 
states that the probability of being at state xn at time tn, given that the system is in xn-
1 at time tn-1, is independent of the state of the process at earlier time steps. This 
indicates that the Markovian process is a memoryless process. We assumed 
Markovian property for the stochastic process of cancer cell division in our model 
that lets us look at the state of cancer stem cells and non-stem cancer cells in a step-
wise manner so that only knowing the current state of the system lets us predict the 
next state. 
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In agreement with the recent work of Laslo and colleagues [Laslo et al. 2006], Till 
and McCulloch proposed that control mechanisms change the fate of hematopoietic 
cells through biasing the probability of each stochastic division incidence. Finally, 
we assumed that tumour microenvironmental factors are biasing and modifying the 
transition probabilities of the stochastic process of cancer cell divisions.  
 
 
3.2.1. Markov process 
For N(t), a time dependent discrete random variable, a Markov process is a 
stochastic process that satisfies: 
p(nk, tk nk−1,...,n1;tk−1,..., t1) = p(nk, tk nk−1, tk−1) (1)
 
where p(n) denotes the probability mass function and p(A B)  is the conditional 
probability of the event A occurring given that the event B occurred.  
According to our last assumption, the process of cell divisions is a stochastic process 
that in each time step the state of the system is determined based on the system state 
at most recent time step that is equivalent to have a (memory-less) independent 
system from far past or future states.  Such a description completely matches a 
Markov process where N(t)=n(t) is a vector representing the number of different 
types of cancer cells at time t.  
We assumed that the Markov process of cancer cell division is a time homogeneous 
process so that the transition probabilities are time-independent. However, we 








3.2.2. Chapman-Kolmogorov equation 
According to the chain rule of probability for any arbitrary stochastic process N(t) 
the following argument is universally true: 
 
p(n1,n2,n3;t1, t2, t3) = p(n3;t3 |n2,n1;t2, t1)p(n2;t2 | n1;t1)p(n1;t1)  (2) 
 
where p(n1,n2,n3;t1,t2,t3) is the joint probability of N(t) to have 
 
(N1(t1),N2 (t2 ),N3(t3)) = (n1,n2,n3)  . 
 
Hence having p(n1;t1)and transition probabilities, one can form a master equation to 
describe the joint probability, p(n1,.n2,n3;t1,.t2, t3). 
Combining the chain rule of probability, equation (2), and the Markovian property of 
stochastic process N(t), equation (1), and assuming the time ordering t1 ≤ t2 ≤ t3we 
have:  
p(n1,...,nk;t1,..., tk ) = p(nk, tk nk−1, tk−1)...p(n2, t2 n1, t1)p(n1;t1)  (3) 
 
Hence having p(n1;t1)and transition probabilities, one can form a master equation to 
describe the joint probability, p(n1,...,nk;t1,..., tk ). 
Seeking for the transition probabilities we return to equation (2) and sum it over all 
values of n2  (as the middle stage of transition): 
p(n1,n3;t1, t3) = p(n1;t1) p(n3, t3 n2, t2 )
n2=−∞
∞
∑ p(n2, t2 n1, t1)
(4)
 
Although equation (4), the Chapman-Kolmogorov Equation, clarifies the relations 
between transition probabilities, it’s still hard to handle to find the general form of 
p(nk; tk).  
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Taking τ’=t3 – t2 in equation (4) and approaching τ’ to 0 we seek for p(n3; t3). Now, 
we define q(n,t;τ) as the probability of a transition occurs between t and t+τ for a 
system that is in state n at time t. Assume that q(n,t;τ) is equal to a(n,t)τ when τ 
approaches 0. For more than one transition between t and t+τ for infinitesimal small 
τ, the probability is o(τ) so that as o(τ)/τ approaches 0.  
We also define ω(n*|n,t) as the probability of transition from state n to n* at time t, 
in accordance with Gillespie’s procedure [Gillespie 1991]. Hence the probability 
that a system in state n at time t transits to state n* at time t* between t and t+τ is 
equal to a(n,t)τω(n*,n| t*). Considering the fact that the probability of no transition 
between t and t+τ is 1-a(n,t)τ so the probability of having the process at state n* at 
t+τ can be written as a Kronecker delta function:  
 













so it is equal to 1 when n=n* and it’s 0 when n≠n*. Therefore the transition 
probability from state n at t to n* can be written as 
 
p(n*, t ** | n, t) = [1−a(n, t)τ ]δn*,n +a(n, t)τω(n* |n, t*)+o(τ ) (5) 
 
where t* is between t and t** and τ=t**- t*.  
Assuming that ω(n*|n,t*) as a smooth function, we can substitute t* with t (that is 
infinitesimally close to t*) in equation(5). Hence we have: 
 
p(n*, t ** |n, t) = [1−a(n, t)τ ]δn*,n +a(n, t)τω(n* |n, t)+o(τ )  (6) 
 
Note that summing over all possible values for n* we have: 
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ω(n* |n, t) =1
n*=−∞
∞
∑   (7) 
In line with the notation used by Van Kampen [Van Kampen 2007], we define W as 
below: 
W(n* |n, t) = a(n, t)ω(n* |n, t)  (8) 
 
Combining equations (7) and (8), we have 
ω(n* |n, t) = W(n* | n, t)




   (9) 
now we use the definition of W, equation (8), to rearrange equation (6):  
 
 p(n*, t ** |n, t) = [1− W(n* |n, t)
n*=−∞
∞
∑ τ ]δn*,n +τW(n* |n, t)+o(τ )    (10) 
Following Van Kampen [Van Kampen 2007], we suppose this stochastic process to 
be a time homogenous Markov process. For a time homogenous Markov process the 
transition probability from one state to another is only based on states rather than 
time i.e. p(n*,t**|n,t)=p(n*|n). Thus, a(n,t)=a(n) and ω(n*|n,t*)= ω(n*|n). Also we 
define: 
a0 (n) = W(n* | n)
n*=−∞
∞
∑   (11) 
Hence, substituting in Equation (10) we have: 
 
p(n*, t ** |n, t) = (1−a0(n)τ )δn*,n +W(n* | n)τ +o(τ )     (12) 
 
Thus, for temporary homogenous Markov processes, the probability of the process 
to be in state n* at t** given that it is in state n at t only depends to the time 
difference between t and t**, τ. For more consistency to the notation used by Van 
Kampen, we designate this probability as Tτ= p(n*,t**|n,t). 
Now we return to the Chapman Kolmogorov Equation (4). Using Tτ instead of 
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p(n*,t**|n,t) in Equation (12 and taking ) and taking τ=t2-t1 and τ’=t3-t2 Van Kampen 
[Van Kampen 2007] proceeded as below to find the rate of change of p(n|t): 
 








Tτ +τ '(n3 |n1) = [(1− a0 (n2 )τ ')δn3,n2Tτ (n2 |n1)
n2=−∞
∞
∑ ]+τ ' W(n3 | n2 )Tτ (n2 |n1)
n2=−∞
∞




Tτ +τ '(n3 |n1) = (1−a0 (n3)τ ')Tτ (n3 |n1)+τ ' W(n3 | n2 )Tτ (n2 |n1)
n2=−∞
∞






Remembering the definition of a0 : 
 
Tτ +τ '(n3 |n1)−Tτ (n2 |n1)
τ '
= −a0 (n3)Tτ (n2 |n1)+ W(n3 |n2 )Tτ (n2 |n1)
n2=−∞
∞






Tτ +τ '(n3 |n1)−Tτ (n2 |n1)
τ '
= − W(n2 |n3)
n2=−∞
∞
∑ Tτ (n3 | n1) + W(n3 |n2 )Tτ (n2 | n1)
n2=−∞
∞
















and considering the fact that o(τ)/τ approaches to 0 for infinitesimal small values of 
τ, we have: 
d
dτ
p(n3, t3 | n2, t2 ) =
d
dτ
Tτ (n3 | n1) = [W(n3 | n2 )
n2=−∞
∞
∑ Tτ (n2 | n1)−W(n2 | n3)Tτ (n3 | n1)] 
(15) 
the above discussion to derive Equation (15) can be found in Turner’s work [Turner 
2009] in detail.  To form a master equation governing the heterogeneous population 
of cancer cells, we use Equation (15). 
 
3.3. Forming the master equation 
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Herein, incorporating the self-renewal, division, differentiation and dedifferentiation 
pathways of cancer cells we form the master equation governing the stochastic 
process of cancer stem cells dynamics, i.e. the population of each phenotype of 



















where Nx(t) represents the number of cancer cells of phenotype x at time t. To use 
Equation (15) we first need to justify the assumptions we made to form Equation 
(15) for the stochastic process of division. 
 
 
3.3.1. Justification of assumptions 
First assumption: the stochastic process of cell division and reprograming is a 
Markov process. Till and colleagues [Till et al. 1964] and more recently Clayton and 
colleagues [Clayton et al. 2007] have used the Markovian property for stem cell 
divisions and were able to successfully reproduce the experimental results. On the 
other hand, mentioned division and reprograming pathways relate the population of 
each Pi to the population of Pi-1 or Pi+1 that is just one step forward or backward. We 
assume that the process of cell division is a memory-less process that only depends 
on the state of the system in short distances (one step forward or backward). That is 
equivalent to Markovian property of a stochastic process. 
Second assumption: the Markov process of cell division and reprograming is a time 
homogenous process. We use the identical set of rates for self-renewal, cancer stem 
cell asymmetric division, cancer stem cell symmetric differentiation, progenitor 
division, progenitor reprograming (dedifferentiation) and the death of totally mature 
cells (M phenotype) regardless to time. As mentioned in section 3.2, these fixed 
rates are denoted by ρS*r1, ρS*r2, ρS*r3, ρP, γ, and Γ respectively. Hence the 
assumption of temporally homogeneity of the process is logical.   
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One may criticise this time-homogeneity assumption stating that the division and 
reprograming rates are dominantly influenced by the tumour microenvironment so 
that for example, the dedifferentiation rate of progenitors in hypoxia or high acidity 
is higher than the rate in normal condition. We took into account this issue by 
considering different sets of transition rates for regions with diverse 
microenvironmental features. We will comprehensively explain the above-
mentioned categorization later in this chapter.  
 
3.3.2. Master equation 
We are interested to find the joint probability of NS(t)=S, NP1(t)=P1, …, NM(t)=M 

























;0) = p(A)  
 
Note that all probabilities are conditioned to initial state although we skip writing for 
simplification. Using Equation (15) and all possible transitions mentioned in section 




p(A) = ρSr1[(S−1)p(S−1,P1,...,M )−Sp(S,P1,...,M )]
+ρSr2[Sp(S,P1 −1,...,M )−Sp(S,P1,...,M )]
+ρSr3[(S+1)p(S+1,P1 − 2,...,M )−Sp(S,P1,...,M )]
+ρP[(P1 +1)p(S,P1 +1,P2 − 2,...,M )−P1p(S,P1,...,M )]
+γ[(P1 +1)p(S−1,P1 +1,P2,...,M )−P1p(S,P1,...,M )]
+ρP[(P2 +1)p(S,P1,P2 +1,P3 − 2,...,M )−P2p(S,P1,...,M )]
+γ[(P2 +1)p(S,P1 −1,P2 +1,...,M )−P2p(S,P1,...,M )]
+ρP[(P3 +1)p(S,P1,P2,P3 +1,P4 − 2,...,M ) −P3p(S,P1,...,M )]
+γ[(P3 +1)p(S,P1,P2 −1,P3 +1,...,M )−P3p(S,P1,...,M )]
+ρP[(P4 +1)p(S,P1,P2,P3,P4 +1,P5 − 2,...,M )−P4p(S,P1,...,M )]
+γ[(P4 +1)p(S,P1,P2,P3 −1,P4 +1,...,M )−P4p(S,P1,...,M )]
+ρP[(P5 +1)p(S,P1,P2,P3,P4,P5 +1,P6 − 2,M )−P5p(S,P1,...,M )]
+γ[(P5 +1)p(S,P1,P2,P3,P4 −1,P5 +1,P6,M )−P5p(S,P1,...,M )]
+ρP[(P6 +1)p(S,P1,P2,P3,P4,P5,P6 +1,M − 2) −P6p(S,P1,...,M )]
+γ[(P6 +1)p(S,P1,P2,P3,P4,P5 −1,P6 +1,M ) −P6p(S,P1,...,M )]




Equation (16) considers all possible transitions to be at state (S, P1, P2, …, M) at 
time t. 
 
3.3.3. Averaging the master equation 
We simplified the interpretation of Equation (16) to the expected values of 
subpopulations. Recall that the definition of expected value for a discrete random 
variable X is: 




To find the expected value of each population we multiplied Equation (16) by 
components of random variable. For instance, we multiplied Equation (16) by S as 
the first step to find the average of the cancer stem cell population. Next, summing 
over all possible states of the system, {A}, and taking the derivative out of the 
















∑    (18) 
where E[S] represent the expected value of cancer stem cells. In the following we 
explain the procedure in detail to find the average values of each subpopulation in 
detail. 
 
3.3.4. Average of cancer stem cell population 












2p S,P−1,...,M( ) −S2p S,P1,...,M( ) 
A{ }
∑
+ρSr3 S S+1( ) p S+1,P1 − 2,...,M( ) −S2p S,P1,...,M( ) 
A{ }
∑
+ρP S P1 +1( ) p P1 +1,P2 − 2,...,M( ) −SP1p S,P1,...,M( ) 
A{ }
∑
+γ S P1 +1( ) p S−1,P1 +1,P2,...,M( ) −SP1p S,P1,...,M( ) 
A{ }
∑
+ρP S P2 +1( ) p S,P1,P2 +1,P3 − 2,...,M( ) −SP2p S,P1,...,M( ) 
A{ }
∑
+γ S P2 +1( ) p S,P1 −1,P2 +1,...,M( ) −SP2p S,P1,...,M( ) 
A{ }
∑
+ρP S P3 +1( ) p S,P1,P2,P3 +1,P4 − 2,...,M( ) −SP3p S,P1,...,M( ) 
A{ }
∑
+γ S P3 +1( ) p S,P1,P2 −1,P3 +1,...,M( ) −SP3p S,P1,...,M( ) 
A{ }
∑
+ρP S P4 +1( ) p S,P1,P2,P3,P4 +1,P5 − 2,...,M( ) −SP4p S,P1,...,M( ) 
A{ }
∑
+γ S P4 +1( ) p S,P1,P2,P3 −1,P4 +1,...,M( ) −SP4p S,P1,...,M( ) 
A{ }
∑
+ρP S P5 +1( ) p S,P1,P2,P3,P4,P5 +1,P6 − 2,M( ) −SP5p S,P1,...,M( ) 
A{ }
∑
+γ S P5 +1( ) p S,P1,P2,P3,P4 −1,P5 +1,P6,M( ) −SP5p S,P1,...,M( ) 
A{ }
∑
+ρP S P6 +1( ) p S,P1,P2,P3,P4,P5,P6 +1,M − 2( ) −SP6p S,P1,...,M( ) 
A{ }
∑
+γ S P6 +1( ) p S,P1,P2,P3,P4,P5 −1,P6 +1,M( ) −SP6p S,P1,...,M( ) 
A{ }
∑




Now we change the labelling of state so that all conditional probabilities change to 

















+ρP [S(P1)p(S,P1,P2,...,M ) −SP1p(S,P1,...,M )]
{A}
∑
+γ [(S+1)(P1)p(S,P1,P2,...,M ) −SP1p(S,P1,...,M )]
{A}
∑
+ρP [SP2p(S,P1,P2,P3,...,M )−SP2p(S,P1,...,M )]
{A}
∑
+γ [SP2p(S,P1,P2,...,M ) −SP2p(S,P1,...,M )]
{A}
∑
+ρP [SP3 + p(S,P1,P2,P3,P4,...,M ) −SP3p(S,P1,...,M )]
{A}
∑
+γ [SP3p(S,P1,P2,P3,...,M ) −SP3p(S,P1,...,M )]
{A}
∑
+ρP [SP4p(S,P1,P2,P3,P4,P5,...,M ) −SP4p(S,P1,...,M )]
{A}
∑
+γ [SP4p(S,P1,P2,P3,P4,...,M ) −SP4p(S,P1,...,M )]
{A}
∑
+ρP [SP5p(S,P1,P2,P3,P4,P5,P6,M ) −SP5p(S,P1,...,M )]
{A}
∑
+γ [SP5p(S,P1,P2,P3,P4,P5,P6,M )−SP5p(S,P1,...,M )]
{A}
∑
+ρP [SP6p(S,P1,P2,P3,P4,P5,P6,M ) −SP6p(S,P1,...,M )]
{A}
∑
+γ [SP6p(S,P1,P2,P3,P4,P5,P6,M )−SP6p(S,P1,...,M )]
{A}
∑




After simplification and considering Equation (18) we form the derivative of the 
average population of cancer stem cell as follows: 
d
dt
S = ρSr1 S − ρSr3 S +γ P1   (19) 
It is clear that changes in the population of cancer stem cells depend on the initial 
population and also on the population of P1 while the reprograming of P1 cells 
increases the S cells population.  
In addition r1, r2, and r3 are not independent. When a cancer stem cell encounters the 
proper conditions to go to the division cycle, it inevitably chooses one of self-
renewal, asymmetric division or symmetric differentiation. Hence r1+r2+ r3 =1. 
Now we define r := r1 - r3 . Knowing r, we can find r2 and for other cases, always r1-





S = ρSr S +γ P1   (20) 
 
 
3.3.5. Average of the progenitors populations 
Following the same procedure as discussed in the pervious section, we form the 
equations to find the expected value for the population of first type of progenitors, 
P1. Note that, herein we have multiplied the original master Equation (16) by P1 and 
then summated over all possibilities for A. revising the labelling as we have done 
before, the master equation in this case reads as follows:            






∑ = ρSr1 P1Sp S,P1,...,M( ) −P1Sp S,P1,...,M( ) 
A{ }
∑
+ρSr2 ( P1 −1)Sp S,P1,...,M( ) −P1Sp S,P1,...,M( ) 
A{ }
∑
+ρSr3 (P1 + 2)Sp S,P1,...,M( ) −P1Sp S,P1,...,M( ) 
A{ }
∑
+ρP P1 P1 −1( ) p P1,P2,...,M( ) −P12p S,P1,...,M( ) 
A{ }
∑
+γ P1 P1 −1( ) p S,P1,P2,...,M( ) −P12p S,P1,...,M( ) 
A{ }
∑
+ρP P1P2p S,P1,P2,P3,...,M( ) −P1P2p S,P1,...,M( ) 
A{ }
∑
+γ (P1 +1)P2p S,P1,P2,...,M( ) −P1P2p S,P1,...,M( ) 
A{ }
∑
+ρP P1P3p S,P1,P2,P3,P4,...,M( ) −P1P3p S,P1,...,M( ) 
A{ }
∑
+γ P1P3p S,P1,P2,P3,...,M( ) −P1P3p S,P1,...,M( ) 
A{ }
∑
+ρP P1P4p S,P1,P2,P3,P4,P5,...,M( ) −P1P4p S,P1,...,M( ) 
A{ }
∑
+γ P1P4p S,P1,P2,P3,P4,...,M( ) −P1P4p S,P1,...,M( ) 
A{ }
∑
+ρP P1P5p S,P1,P2,P3,P4,P5,P6,M( ) −P1P5p S,P1,...,M( ) 
A{ }
∑
+γ P1P5p S,P1,P2,P3,P4,P5,P6,M( ) −P1P5p S,P1,...,M( ) 
A{ }
∑
+ρP P1P6p S,P1,P2,P3,P4,P5,P6,M( ) −P1P6p S,P1,...,M( ) 
A{ }
∑
+γ P1P6p S,P1,P2,P3,P4,P5,P6,M( ) −P1P6p S,P1,...,M( ) 
A{ }
∑












P1 = ρSr2 S + 2ρSr3 S − ρP P1 −γ( P1 − P2 )  (22) 
 




P1 = (1− r )ρS S − ρP P1 −γ ( P1 − P2 )    (23) 
 
Similar to the procedure used to derive the expected value for P1, the averages of 
other progenitors are as listed below. For convenience, the expected values of cancer 





S = ρSr S +γ P1                                     (24) 
d
dt
P1 = (1− r )ρS S − ρP P1 −γ ( P1 − P2 )   (25) 
d
dt
P2 = ρP(2 P1 − P2 ) −γ ( P2 − P3 )         (26) 
d
dt
P3 = ρP(2 P2 − P3 ) −γ ( P3 − P4 )         (27) 
d
dt
P4 = ρP(2 P3 − P4 )−γ ( P4 − P5 )         (28) 
d
dt
P5 = ρP(2 P4 − P5 )−γ ( P5 − P6 )         (29) 
d
dt
P6 = ρP(2 P5 − P6 )−γ P6                      (30) 
d
dt
M = 2ρP P6 − Γ M                                 (31)   
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Solving the above system of differential equations at the steady state, results in the 
answers in terms of one of the phenotypes, ρS, ρP, γ, and Γ. Although the results may 
seem to be useful, their dependence on the transition rates leaves them inapplicable. 
Hence, tuning the transition rates is the preliminary stage to solve the system. 
Recalling the dominant effect of the tumour microenvironment on tumour growth, 
cancer progression and specifically, cancer stem cell maintenance we classified the 
transition rates based on the affecting microenvironmental factors.  
Current work is focused on the effect of hypoxia and high acidity on transition rates 
and consequently tumour survival and growth.  
 
 
3.4. Tuning the transition rates  
To tune the transition rates, we used a deterministic filtration and next applied a 
stochastic procedure. Using an exhaustive key search on ρS, ρP, r, and γ, we first 
found the proper combinations of transition rates, which satisfy a deterministic test 
on capability of a system to produce a predetermined fraction of stem cells at steady 
state in accordance with biological data. Second, we used a stochastic approach to 
filter the results of the first part once more comparing the ability of the subsequent 
system to form neurospheres. Again, the results have been selected in accordance 
with the neurosphere essay experiments.   
 As mentioned before, the low accuracy of available neural stem cell biomarkers and 
the contradictory results of experiments done on non-stem cancer cells to show the 
properties of cancer stem cells convinced us to consider the first four phenotypes of 
the system as cancer stem cells and others as non-stem cancer cells. Thus we 
assumed that S, P1, P2, and P3 cells express CD133+ while P4, P5, P6, and M cells 
are CD133- cells.  
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3.4.1. Microenvironmental features categorization 
The oxygen concentration is known to have a profound effect on the cancer cells 
survival and progression. In addition to mediating survival and proliferation, oxygen 
levels in the brain affect the cell metabolism, cell signalling and gene expression 
[Heddleston et al. 2010, Keith and Simon 2007, Seidel et al. 2010, Heddleston et al. 
2009, Fukumura et al. 2001, Hjelmeland et al. 2011, Pouyssegur et al. 2006, Gordan 
and Simon 2007]. Many studies have reported that the reduction in oxygen 
concentration (from 20% t0 3-5%) promotes the stem-like properties of cancer cells 
[Ivanovic et al. 2004, Kovacevic-Filipovic et al. 2007, Studer et al. 2000, Zhang et 
al. 2006]. Although, Tofilon and colleagues claim that 20% of oxygen concentration 
considered in in vitro studies (atmospheric condition) is fairly high for culturing 
GBM cells, they demonstrated same argument that hypoxia upregulates the cancer 
stem cell phenotype [McCord et al. 2009]. Mentioning that oxygen level is 14% in 
alveolar [Guyton and Hall 2006], 5-10% in normal brain tissue [Evans et al. 2004, 
Dings et al. 1998], 0.1-10% in a GBM tumour tissue [Evans et al. 2004a, b, Dings et 
al. 1998], and 6-7% for majority of GBM cells [Evans et al. 2004] and comparing 
their experiments results under 7% of oxygen with other studies under normal 
culture condition of 20% of oxygen, Tofilon and colleagues demonstrated the 
promotion of self-renewal, differentiation potentials, and enhanced stem-like 
genomic and protein-expression of GBM tumour stem cell cultures under the 
hypoxic condition [McCord et al. 2009]. With an emphasis on recruitment of HIF2α 
in GBM cancer stem cell culture. Heddleston et al. [Heddleston et al. 2009] and 
Acker and colleagues [Seidel et al. 2010] have also reported the promoting effect of 
hypoxia on the cancer stem cell phenotype.  
Likewise the hypoxia, high acidity of the tumour microenvironment dominantly 
affects the maintenance of cancer stem cells. Recently, Rich and colleagues have 
reported the results of their experiment investigating the influence of high acidic 
stress in the tumour microenvironment on cancer cells [Hjelmeland et al. 2011]. 
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They state that initiating with cancer stem cell-depleted cultures, fraction of cancer 
cells expressing the CD133+ and colony formation ability increased under the acidic 
condition (pH=6.5), while the elevation of extracellular pH, from 6.5 to 7.5 reduces 
the expression of cancer stem cell marker, CD133, and neurosphere formation 
potentials [Hjelmeland et al. 2011]. Although the pH level inside the GBM tumour 
has been reported to be as low as 5.9, the differences of outcomes under normal 
(7.1-7.5 )[vaupel et al. 1989]) and acidic conditions differs considerably. Even 
before the popularity of the cancer stem cells hypothesis, Casciari and colleagues 
reported that the growth rate of tumour cells increases under acidic condition 
[Casciari et al. 1992]. Moreover, they compared the correlation of growth rate with 
oxygen concentration as well as glucose content. Additionally, they investigated the 
simultaneous effect of acidity and hypoxia on tumour growth. Their results showed 
that under hypoxic conditions the growth rate of a tumour decreases as the pH level 
decreases. This may appear to contradict the effect of hypoxia and acidity in 
promoting tumour progression, but the coincidence of both hypoxia and acidity may 
lethally modify the tumour microenvironment so that not only normal cells but also 
cancer cells can not survive. Jain’s group has reported results that do not support the 
additive effect of simultaneous hypoxia and acidity on tumour tissue [Fukumura et 
al. 2001]. In their study on upregulation of VEGF by hypoxia and acidity in brain 
tumours [Fukumura et al. 2001], they claim that, although the effect of hypoxia and 
acidity independently upregulate VEGF, the recruitment of VEGF under 
simultaneous hypoxia and acidity is less than the summation of the effect of each in 
separate experiments. Their justification to explain the sub-linear effect of hypoxia 
and acidity is the same as the reasoning of Casciari et al. (1992). 
Thus, focusing on hypoxia and acidity as dominant features of the GBM tumour 
microenvironment, we have divided the microenvironmental space into four 
different regions of, normal, hypoxic, acidic and hypoxic-acidic sub-regions (Table 




Table 1: Microenvironmental heterogeneity inside cancer tumours. Oxygen 
concentration and acidity of tumour microenvironment as the dominant determiners 
of tumour progression divide the tumour microenvironment to four sub-region of 
hypoxic acidic, hypoxic non-acidic, normoxic acidic, and normal. 
 








pH<6.5 and pO2≈21% pH≈7.5 and pO2≈21% 
 
 
In the following sections, we demonstrate the deterministic and stochastic filtration 
of transition rates, in which we obtain separate sets of results for each sub-region 
mentioned above. Hence at the end of the filtration, four sets of transition rates for 
hypoxic, acidic, hypoxic-acidic, and normal regions are provided. 
 
 
3.4.2. Deterministic filtration  
The saturation of the fraction of stem cells [Turner 2009], including S cells, P1, P2, 
and P3 cells in current model, suggested to us that we should carry out the filtration 
based on the reported fraction of CD133+ cells in experiments. Table 2 explains the 
biological experiments done by different research groups on fraction of GBM cancer 
stem cells. In silico model assumptions are designed to match the conditions of the 
discussed biological experiments.  
In their experiment, Rich and colleagues [Heddleston et al. 2009] have cultured 
glioma non-stem cancer cells from a human patient specimen in 24 well plates at a 
density of 10 cells per well. Then they immediately subject the cultures to hypoxic 
condition (2% O2) or normoxic condition (21% O2) for 9 days (p<0.05) 
[Heddleston et al. 2009]. Experiments 1 and 2 in Table 2 represent a summary of 
their experiments. Acker’s group has reported comparable results from their 
experiment [Seidel et al. 2010]. To investigate the effect of an acidic 
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microenvironment on cancer stem cell fraction, Hjelmeland et al. [Hjelmeland et al. 
2011] have culture a glioma stem cell- depleted bulk of 5 cancer cells under pH level 
of 6.5 for 10 days. Their conditions and results are summarized in Table 2. 
To simulate the experimental conditions, we considered a random combination of 
non-stem cancer initiating cells so that ten initiating cells are randomly chosen from 
among P4, P5, P6, and M cells. Using a brute force method we have selected those 
combinations of transition rates that gave a proper fraction of cancer stem cells as 
reported in biological data. Brute force method (aka proof of exhaustion or proof by 
cases) checks the validity of the statement of the question for finite number of cases 
and selects those ones which the proposition in the question holds for.   
Note that fraction of cancer stem cells is the fraction of the summation of S, P1, P2, 
and P3 cells to the total number of cancer cells in the culture. Table 3 explains the 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The only region that is not covered in biological experiments in Table 2 and 
simulations in Table 3 is the hypoxic- acidic region. To the knowledge of the author, 
no one has tried to see the explicit effect of the coincidence of hypoxia and acidity 
on cancer stem cells. However, valuable studies of Jain and colleagues [Fukumura et 
al. 2001] and also Casciari’s group [Casciari et al. 1992] of the upregulation of 
VEGF and tumour growth rate respectively have shed light on the simultaneous 
effect of hypoxia and acidity. We predict that considering the lethal condition of an 
acidic and hypoxic extracellular condition, the fraction of cancer stem cells is not the 
summation of fractions of hypoxic and acidic regions, although the effect of hypoxia 
and acidity on VEGF is known to be independent in brain tumours [Fukumura et al. 
2001]. Hence, we formed a simulation as shown in Table 4, to find the matching 
combination of transition rates for the hypoxic and acidic region.  
 
 
3.4.3. Results of deterministic filtration 
Solving the system of differential equations (Equation 24 to 31), we picked those 
combinations of transition rates, which were able to generate the same fraction of 
cancer stem cells as reported in biological experiments (Table 2). Among different 
feasible combinations of transition rates we have filtered at most 630 combinations 
out of 50000 initial combinations. These results fed the second round of simulations 
and have been filtered again based on a stochastic criterion of the ability to form the 














































































































































































































































































































































































3.4.4. Gillespie’s algorithm and neurosphere essays 
In spite of a saturation state for the fraction of cancer stem cells, the number of 
cancer cells will not be saturated essentially. Thus, to solve the system of differential 
equations (Equation 24 to 31) the solution at steady state cannot be accepted.  
Gillespie’s algorithm is one of the alternatives to gain a suitable trajectory of the 
system and solution(s). Popularized by Dan Gillespie, Gillespie’s algorithm has been 
formed to simulate the time evolving behaviour of chemical or biological systems, 
which have small number of reactants [Gillespie 1977]. The method produces a 
good prediction of stochastic process based on the initial condition of reactants, 
reactions, and transition rate of each reaction. The first step to use the Gillespie’s 
algorithm is to form the matrix of reactions and vector of transition rates of 
reactions.  
Herein, we form the stoichiometry matrix (SM), the reaction matrix, for the 
proposed model. Recalling the transition pathways of cancer cells, we assign each 
transition pathway to be as a row in stoichiometry matrix. Considering each cell type 
as a reactant and assigning each to a column in stoichiometry matrix we form a 16*8 
matrix containing the information about the transition pathways and cell types so 
that SM (i, j) is equal to the number of cell type j increasing (+) or decreasing (-) 
through the transition i. Hence, for the proposed model the stoichiometry matrix is 
as follows in the next page.  
The transition rates for each state form the propensity vector. The size of the vector 
is equal to the number of reaction (transition pathways) and each element stores the 
transition rate for the corresponding transition so that the i-th element is the 
transition rate for i-th transition. Considering A= (S, P1, …, M) as the current  sate 
of the system, the propensity vector (VP) for the current model is as follows: 
 








1 0 0 0 0 0 0 0
0 1 0 0 0 0 0 0
−1 2 0 0 0 0 0 0
0 −1 2 0 0 0 0 0
1 −1 0 0 0 0 0 0
0 0 −1 2 0 0 0 0
0 1 −1 0 0 0 0 0
0 0 0 −1 2 0 0 0
0 0 1 −1 0 0 0 0
0 0 0 0 −1 2 0 0
0 0 0 1 −1 0 0 0
0 0 0 0 0 −1 2 0
0 0 0 0 1 −1 0 0
0 0 0 0 0 0 −1 2
0 0 0 0 0 1 −1 0















































Briefly, Gillespie’s algorithm randomly choses one of the rows of the stoichiometry 
matrix based on the assigned weight in the propensity matrix. Thus, although the 
selection of a transition pathway is random, rows corresponding to higher transition 
rates are more likely to be selected. The next step after selecting a reaction or 
transition is the revision of all reactants or cell types based on the selected reaction. 
This procedure will continue and move forward with random time steps till the 
maximum time is met.   
Neurosphere essay and colony formation is a functional property of cancer stem cell. 
Hence, beside the expression of CD133+ as a physiological property, the capability 
of cell cultures in forming neurospheres is a sign of the presence of cancer stem 
cells. Using Gillespie’s algorithm, we have formed a set of simulations to re-filter 
the transition rates resulted from deterministic filtration. Each simulation has been 
run for 1000 times and experimental conditions such as the combination of initiating 
cells and extracellular hypoxia or acidity were fixed according to corresponding 
biological data. The biological experiments and simulations are summarized in Table 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Double filtration of transition rates by deterministic criterion of the formed fraction 
of cancer stem cells and the stochastic norm of neurosphere formation potentials left 
us with a few combinations of rates that can be easily clustered and analysed.  
At the first step the transition rate value assignment by a brute force method resulted 
in 50000 sets of transition rates as input where ρS, ρP, γ, and r were changing.  
As mentioned before, Γ is assumed to be an infinitesimally small number (Γ≈ 0) in 
all simulations. Moreover r1, r2, and r3 are dependent values summing to 1. We 
considered r in the first set of deterministic simulations and then in the second round 
of stochastic ones, we expand it over different possibilities of r1, r2, and r3. Hence, 
the effect of different combinations of r1, r2, and r3 (for a fixed value of r) is also 
considered. Table 7-10 contain the final results for transition rates. The diversity of 
results ranges between 2 to 41 different sets of transition rates. The hypoxic region 
with 41 sets of results has the largest data size while hypoxic-acidic region, normal 
and acidic region data sizes are decreasing with 17, 9 and 2 sets of transition rates as 
results.  
Considering the diversity of results provokes the question of whether the results of 
each region are clustered into different groups. We first tried to figure out the 
clustering of results by a visual inspection of the graphs. Figures 1 to 4 illustrate the 
positions of results in each region. Note that values of ρS, and ρP are equal and the 
values of r1, r2, and r3 are dependent. These make it possible for us to investigate the 
correlation of different results in one region by considering the relationship between 
γ, r2, and r3. 
Figures 1 to 3 suggest that there may be different clusters of the results in each 
region, the position of results over all microenvironmental regions imply that the 
inter-region clustering can be neglected. Figure 4 simultaneously shows the results 
loci for all regions. 
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Table 7: &ormal region, resulted transition rates (9 sets) for normal regions. These 
results produce 15%(±1%) cancer stem cells in culture and form neurospheres in 
8.3% (±0.03%) of wells. The experimental conditions and simulations assumption 
can be found in Table 2-6. 
 
 Set ρS ρP r r1 r2 r3 γ 
1 0.6931 0.6931 -0.90 0.05 0.00 0.95 0.47 
2 0.6931 0.6931 -0.80 0.00 0.20 0.80 0.47 
3 0.6931 0.6931 -0.70 0.15 0.00 0.85 0.45 
4 0.6931 0.6931 -0.50 0.00 0.50 0.50 0.44 
5 0.6931 0.6931 -0.50 0.05 0.40 0.55 0.46 
6 0.6931 0.6931 -0.40 0.05 0.50 0.45 0.45 
7 0.6931 0.6931 -0.30 0.35 0.00 0.65 0.43 
8 0.6931 0.6931 -0.30 0.05 0.60 0.35 0.44 






Table 8: Acidic region, resulted transition rates (2 sets) for acidic region. These 
results produce 30%(±1%) cancer stem cells in culture and form neurospheres in 
20% (±0.03%) of wells. The experimental conditions and simulations assumption 
can be found in Table 2-6. 
 
Set ρS ρP r r1 r2 r3 γ 
1 0.6931 0.6931 -0.50 0.00 0.50 0.50 0.68 




Table 9: Hypoxic region, resulted transition rates (17 sets) for hypoxic region. These 
results produce 45%(±1%) cancer stem cells in culture and form neurospheres in 
21% (±0.03%) of wells. The experimental conditions and simulations assumption 
can be found in Table 2-6. 
 
 Set ρS ρP r r1 r2 r3 γ 
1 0.6931 0.6931 -0.90 0.00 0.10 0.90 0.93 
2 0.6931 0.6931 -0.80 0.05 0.10 0.85 0.91 
3 0.6931 0.6931 -0.70 0.00 0.30 0.70 0.90 
4 0.6931 0.6931 -0.70 0.10 0.10 0.80 0.92 
5 0.6931 0.6931 -0.70 0.05 0.20 0.75 0.92 
6 0.6931 0.6931 -0.60 0.20 0.00 0.80 0.89 
7 0.6931 0.6931 -0.60 0.15 0.10 0.75 0.89 
8 0.6931 0.6931 -0.60 0.10 0.20 0.70 0.89 
9 0.6931 0.6931 -0.50 0.25 0.00 0.75 0.89 
10 0.6931 0.6931 -0.50 0.20 0.10 0.70 0.89 
11 0.6931 0.6931 -0.50 0.10 0.30 0.60 0.89 
12 0.6931 0.6931 -0.50 0.05 0.40 0.55 0.89 
13 0.6931 0.6931 -0.50 0.20 0.10 0.70 0.90 
14 0.6931 0.6931 -0.50 0.15 0.20 0.65 0.90 
15 0.6931 0.6931 -0.50 0.05 0.40 0.55 0.91 
16 0.6931 0.6931 -0.40 0.10 0.40 0.50 0.87 
17 0.6931 0.6931 -0.40 0.05 0.50 0.45 0.87 
18 0.6931 0.6931 -0.40 0.25 0.10 0.65 0.88 
19 0.6931 0.6931 -0.40 0.15 0.30 0.55 0.88 
20 0.6931 0.6931 -0.40 0.00 0.60 0.40 0.88 
21 0.6931 0.6931 -0.30 0.30 0.10 0.60 0.86 
22 0.6931 0.6931 -0.30 0.20 0.30 0.50 0.86 
23 0.6931 0.6931 -0.30 0.00 0.70 0.30 0.86 
24 0.6931 0.6931 -0.30 0.35 0.00 0.65 0.87 
25 0.6931 0.6931 -0.30 0.15 0.40 0.45 0.87 
26 0.6931 0.6931 -0.30 0.10 0.50 0.40 0.87 
27 0.6931 0.6931 -0.30 0.05 0.60 0.35 0.87 
28 0.6931 0.6931 -0.30 0.00 0.70 0.30 0.87 
29 0.6931 0.6931 -0.30 0.25 0.20 0.55 0.88 
30 0.6931 0.6931 -0.30 0.20 0.30 0.50 0.88 
31 0.6931 0.6931 -0.30 0.15 0.40 0.45 0.88 
32 0.6931 0.6931 -0.20 0.05 0.70 0.25 0.84 
33 0.6931 0.6931 -0.20 0.00 0.80 0.20 0.85 
34 0.6931 0.6931 -0.20 0.25 0.30 0.45 0.87 
35 0.6931 0.6931 -0.20 0.10 0.60 0.30 0.87 
36 0.6931 0.6931 -0.20 0.05 0.70 0.25 0.87 
37 0.6931 0.6931 -0.10 0.25 0.40 0.35 0.83 
38 0.6931 0.6931 -0.10 0.05 0.80 0.15 0.83 
39 0.6931 0.6931 -0.10 0.00 0.90 0.10 0.83 
40 0.6931 0.6931 0.00 0.05 0.90 0.05 0.83 









Table 10: Acidic-hypoxic region, resulted transition rates (17 sets) for acidic-
hypoxic region. These results produce 37.5%(±1%) cancer stem cells in culture and 
form neurospheres in 15% (±0.03%) of wells. The experimental conditions and 





Set ρS ρP r r1 r2 r3 γ 
1 0.6931 0.6931 -0.10 0.25 0.40 0.35 0.72 
2 0.6931 0.6931 0.00 0.40 0.20 0.40 0.70 
3 0.6931 0.6931 0.00 0.30 0.40 0.30 0.70 
4 0.6931 0.6931 0.00 0.25 0.50 0.25 0.70 
5 0.6931 0.6931 0.00 0.40 0.20 0.40 0.71 
6 0.6931 0.6931 0.00 0.50 0.00 0.50 0.72 
7 0.6931 0.6931 0.00 0.45 0.10 0.45 0.72 
8 0.6931 0.6931 0.10 0.40 0.30 0.30 0.67 
9 0.6931 0.6931 0.10 0.50 0.10 0.40 0.68 
10 0.6931 0.6931 0.10 0.40 0.30 0.30 0.68 
11 0.6931 0.6931 0.10 0.30 0.50 0.20 0.68 
12 0.6931 0.6931 0.10 0.20 0.70 0.10 0.68 
13 0.6931 0.6931 0.10 0.15 0.80 0.05 0.68 
14 0.6931 0.6931 0.10 0.35 0.40 0.25 0.69 
15 0.6931 0.6931 0.10 0.30 0.50 0.20 0.69 
16 0.6931 0.6931 0.20 0.30 0.60 0.10 0.66 
17 0.6931 0.6931 0.20 0.25 0.70 0.05 0.66 
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Figure 1:  Transition rates for normal region. Each point represents one 
combination of resulted transition. Since ρS, and ρP are equal and fixed over all 
regions, the answer space can be defined by γ, r2, and r3. 
 
 
Figure 2: Transition rates for hypoxic region. Each point represents one 
combination of resulted transition. Since ρS, and ρP are equal and fixed over all 






Figure 3: Transition rates for acidic-hypoxic region. Each point represents one 
combination of resulted transition. Since ρS, and ρP are equal and fixed over all 


















Figure 4: Comparison of transition rates for different regions. Blue, green, red, and 
yellow represent the transition rates for normal, acidic, hypoxic, and acidic-hypoxic 
regions respectively. Although the rates for each region seem to be clustered in 
different groups, the distance among transition rates for different regions are large 
enough to make the intera-region differences negligible. Second graph shows the 








As illustrated in Figures 1 to 3, our results for each region may belong to two or 
three different clusters. However, the overall comparison of all regions (Figure 4) 
suggests that the average of each set of results can properly represent and 
characterize the entire set. In addition to summarizing data for one combination of 
transition rates for each region, we also compare and interpret the 
microenvironmental effects on division, differentiation, and self-renewal of cancer 
stem cells as well as the modifications of non-stem cancer cells division and 
dedifferentiation.  
 
3.6.1. Hypoxia, dedifferentiation and symmetric 
differentiation 
Figure 5 shows the prominent promotion of dedifferentiation in the hypoxic region. 
Non-stem cancer cells located in the normal region have the lowest rate of 
reprograming. Although acidic and hypoxic-acidic regions clearly up regulate the 
dedifferentiation, the hypoxic region shows the largest proportion of non-stem 
cancer cell reprograming (0.8 to 0.9).   
We hypothesize that hypoxia up regulates the cancer stem cell phenotype through 
the promotion of dedifferentiation of non-stem cancer cells. On one hand, this 
hypothesis is supported by all biological experiments used in constructing the 
model, and on the other hand, it can be expanded to justify experimental results 
obtained by other research groups. For instance, Philips and colleagues [Chen et al. 
2010] have proposed a hierarchy of cancer cells that are able to initiate and maintain 
Gliomas.  According to their experiments (done in 3% oxygen), a subgroup of non-
stem cancer cells are at the top of hierarchy and are able to generate cancer stem 
cells as well as non-stem cancer cells. They have proposed that the capability of this 
subgroup of non-stem cancer cells to promote tumour progression is even higher that 
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those cancer stem cells marked by the neural stem cells marker, CD133+. Our model 
and resulting transition rates can explain their results. Since hypoxia prominently 
promotes dedifferentiation of non-stem cancer cells, tumour progression and cancer 
stem cells maintenance are dominantly affected by reprograming of non-stem cancer 
cells rather than the self-renewal of cancer stem cells. Thus in hypoxic regions, the 
population of less-mature non-stem cancer cells may be larger than other regions. 
Another identified characteristic of the transition rates in hypoxic region is the 
augmented transition rate for symmetric differentiation of cancer stem cells (r3). The 
variance is clearly apparent when compared to its counter part in normal regions.  
 
Figure 5: Distribution of results for four regions, normal(blue), Acidic (green), 
Hypoxic (red), and Acidic-hypoxci (yellow). The points are clearly devided based on 
the dedifferentiation and symmetric differentaition rates for each region (Except the 








3.6.2. Acidity and dedifferentiation 
Figure 6 demonstrates the loci of each region results in γ, r1 plane. Although in 
Figure 5 the locus of acidic region results and acidic-hypoxic region seem to be 
merged, Figure 6 illustrates the clear differences between r1 values for the two 
results sets for acidic and acidic-hypoxic regions. Our simulation results also show a 
sharp decrease of r1 values in acidic region though the dedifferentiation of non-stem 
cancer cells has significantly increased compared to normal regions. 
 
Figure 6: Distribution of results for four regions, normal(blue), Acidic (green), 
Hypoxic (red), and Acidic-hypoxci (yellow). The points are clearly devided based on 
the dedifferentiation and self-renewal rates for each region). Although acidic and 
acidic-hypoxic regions equally affect the dedifferentiation, they differ considarably 








3.6.3. Acidic-hypoxic regions and self-renewal 
According to our simulation results the coincidence of hypoxia and acidity mostly 
promotes the self-renewal of cancer stem cells (Figure 7). The distribution of results 
for different regions in the r1, r3 plane illustrates that the self-renewal rate for cancer 
stem cells residing in acidic-hypoxic region is much higher than for those in regions 
under normal microenvironmental conditions. The transition rate for symmetric 
differentiation of cancer stem cells in acidic-hypoxic areas is also considerably less 
than for those in normal, acidic and hypoxic regions. In addition, the 
dedifferentiation of non-stem cancer cells in acidic hypoxic regions is almost the 
same as for those in acidic regions.  
Based on our simulation results we hypothesize that acidic-hypoxic regions promote 
tumour progression and cancer stem cell maintenance through the up regulation of 
cancer stem cell self-renewal. This hypothesis also justifies the experimental results 
reported by Fukumura et al. [Fukumura et al. 2001] about the non-additive effect of 
simultaneous hypoxia and acidity on tumour progression. Although the 
dedifferentiation rate in hypoxic areas is much higher than in acidic regions, the rate 
in acidic-hypoxic regions is equal to that in areas with high acidity. In addition, self-
renewal promotion in both hypoxic and acidic regions is considerably less than that 
in acidic-hypoxic regions. Thus, rather than having an average effect of independent 
exposure to hypoxia and acidity, we noticed an independent effect of simultaneous 












Figure 7: Distribution of results for four regions, normal(blue), Acidic (green), 
Hypoxic (red), and Acidic-hypoxci (yellow). The points are clearly devided based on 
the symmetric differentiation and self-renewal rates for each region. Acidic-hypoxic 
region shows the most domimnant effect on self-renewal, while the symmetric 










3.6.4. Implications for cancer therapy 
As modern cancer therapies are improving to target specific cell types, the need for 
identifying which cell type(s) to target is becoming increasingly important. The 
aforementioned results can provide a hint as to which subpopulation(s) of cancer 
cells may be the critical group to target, based on the instantaneous state of the 
tumour.  
The self-renewal down-regulation of cancer stem cells and simultaneous 
dedifferentiation promotion in acidic regions necessitates the selection of a therapy 
that focuses on cancer progenitors. Likewise, since the dedifferentiation rate of 
cancer progenitors is highly augmented in hypoxic regions, selecting a therapy that 
primarily targets progenitors is more appropriate. However, the self-renewal of 
cancer stem cells is higher than normal regions. Thus, the therapy secondary target 
must be cancer stem cells. In an acidic-hypoxic region, the promotion of cancer stem 
cells is higher than in hypoxic and acidic regions; therefore a suitable therapy must 
focus on cancer stem cells while not neglecting cancer progenitors because of the 









4. Simulated tumour growth 
In this chapter we use a cellular automaton model to investigate the growth dynamic 
of cancer cells under tumour microenvironment condition. We developed our model 
by considering the effect of the extracellular matrix inside the tumour tissue, cellular 
heterogeneity, division and dedifferentiation, and cell pushing. 
 
4.1. Cellular automata model 
Implication of cellular automata in cancer modeling has been pioneered by Düchting 
and Vogelsaenger to model the effect of radiotherapy on cancer tumours [Duchting 
and Vogelsaenger 1984] and has rapidly become popular  [Deutsch and Dormann 
2005]. Among more recent models, the model proposed by Ferreira et al. of tumour 
morphology [Ferreira et al. 2002], the model proposed by Patel et al. of cell 
metabolism and invasion with a focus on the glycolytic phenotype [Patel et al. 
2001], and Anderson’s model of tumour invasion [Anderson 2005], are current 
cellular automaton models of cancer growth. Ferreira’s model considered the 
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concentration of nutrients in the tumour microenvironment and formed a 
probabilistic model that generates matching nutrient consumption heterogeneities to 
available biological experiments [Ferreira et al. 2002]. Patel et al. emphasized the 
metabolic differences and heterogeneities affected by vessel density inside the 
tumour [Patel et al. 2001]. However, like Ferreira and colleagues’ work [Ferreira et 
al. 2002], they only considered one phenotype of cancer cells residing in a 
continuous field of chemicals in their hybrid cellular automaton model.  As an 
improvement, Anderson has added different phenotypes of cancer cells to his 
proposed model [Anderson 2005]. Although Anderson has considered the 
heterogeneity of cancer cells, the random assignment of cell phenotypes to new 
cancer cells disconnects the cellular automata from the tumour microenvironment. 
Kansal et al. [Kansal et al. 2000a, b] formed a three-dimensional cellular automaton 
model to investigate the growth of GBM. They have used a Voronoi representation 
rather than cubic representation. In the Voronoi representation, the grid sizes vary 
and consequently the formed tumour is geometrically more similar to biological 
observations. Following this, Mansury et al. [Mansury et al. 2006] have upgraded 
Kansal’ model by adding two different subpopulations of proliferative or migrating 
cancer cells and using game theory to investigate the system ‘pay-off’ for each 
subpopulation. The interaction of cancer cells and the tumour microenvironment 
was previously studied by the same group in and agent-based model of brain cancer 
growth [Mansury et al. 2002].  Gatenby and Vincent [Gatenby and Vincent 2003] 
have used game theory and continuous population dynamic approaches to identify 
essential conditions for tumour invasion. They have proposed that the failure of 
ordinary cytotoxic treatment is due to the adaptation of cancer cells to their new 
microenvironment.  
Herein, we introduce a two- dimensional cellular automaton model composed of 8 
different phenotypes of cancer cells all are residing in a 20µm-square lattice and 
each behaving distinctly from the others in response to microenvironmental 
conditions and its neighbouring cells. Cell phenotypes that are different agents in the 
model can affect the fate of other cells through nutrient consumption, blocking of 
proliferating cells, or pushing other cells to make space for their division.  
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4.1.1. Cell division 
The same division pathways used in the previous chapter are implemented in a 
square lattice of cellular automata to model the proliferation of cancer cells. Each 
cell can have three different states of proliferation, quiescence and death. We will 
extensively describe conditions that bring a cell to a proliferative, quiescent or dead 
cell in future section of this chapter. Regardless of the reasons that lead to each of 
above-mentioned states, the model runs a different algorithm for each. So that a 
dead cell is considered as a blocking obstacle for neighbouring cells’ proliferation 
and movement until the debris are all collected. A quiescent cell remains in a non-
proliferative state unless the conditions that caused quiescence change. Finally, a 
proliferative cell goes through division pathways unless it is an M cell that cannot 
proliferate anymore. We designed our cellular automata to be traceable so that for 
each present cell in the square lattice, the type of the cell and previous proliferation 
state are known and help to determine the current proliferation state and the type of 
daughter cell after division or dedifferentiation. The preliminary layout of the 
initiating cells is arbitrary, though in the presented simulations they are 
approximately located in the centre. The types of initiating cells are selected to 
match the conditions of neurosphere assay experiments. The placement of new cells 
after division are decided according to vacancy of four possible neighbouring 
positions of parent cells (up, down, left, and right), considering one of the daughter 
cells take the place of the parent cell. If there is more than one vacancy, a position is 
randomly picked. However, the occupancy of all positions does not necessarily lead 
the parent cell to a quiescent state; in this case cancer cells may try to push 
neighbouring cells to make some space for new daughters. The mechanisms to run 





Each cell agent may be able to proliferate even if all its four neighbouring positions 
are occupied. We consider a fixed pushing radius for all cell types (equal to 5 cell) in 
our cellular automata model. A proliferating cell surrounded by other cells can push 
its neighbours to the closest vacant position at most 5 cells away. Hence, even a cell 
blocked at the center of 11 by 11 square lattice of cells may divide if other necessary 
conditions are satisfied.  
The pushing mechanism implemented in our model is as follows: a counter finds the 
vertically or horizontally closest vacant position in lattice. The counter cancels the 
process if it reaches an obstacle. The obstacle may be a dead cell or a vacant position 
with improper extracellular matrix condition where neither the required level of 
adhesion nor the acceptable ranges of pressure are satisfied. As the next step, the 
counter will be checked for the maximum radius of pushing allowed in the model 
(herein, we fixed it for 5). If it passes this step, the whole chain of cells from the 
parent cell to the vacant position will be moved to make empty the neighbouring 
position of proliferating cells. If the counter points to a position out of the allowed 
range, the proliferative cell is doomed to quiescence. Figure 9 shows the flowchart 
of the simulation and the certain step of Pushing process implementation.   
 
4.1.3. Implementation of extracellular matrix 
Cells viability and activities are closely dependent on an adequate level of adhesion 
to and proper range of pressure from the surrounding matrix. We simplified the 
effect of cell adhesion and surrounding pressure to a randomly assigned matrix. This 
matrix, which we call the ECM matrix hereafter, plays the role of the extracellular 
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matrix as well as the probable presence of normal cells inside the tumour tissue. As 
an improvement to the current model, the ECM matrix can be modified to better 
match the biological features of Extracellular matrix inside the tumour tissue.  
 
4.2. Cell metabolisms 
The tendency of cancer cells to switch to a glycolytic metabolism, even in the 
presence of adequate content of oxygen, known as Warburg effect, sheds light on the 
importance of both cell metabolisms in tumour progression and microenvironmental 
modifications. Hence, in tumour tissue (not only in hypoxic regions but also in 


























− + 2H + + 2ATP 
 
Comparing the respiration and glycolysis reaction equations, the production of 
energy (ATP) for one molecule of glucose in respiration is 18 folds the amount 
produced by glycolysis. On the other hand, the presence of hydrogen ions among 
glycolysis metabolism products introduces the glycolysis acidic effect. Despite of 
the existence of a natural prominent buffering system in soft tissues, that is the 
interconversion of bicarbonate (HCO3
−) and carbon dioxide (CO2), increase of 
concentration of hydrogen ions (H
+
) causes an indispensible effect on interstitial pH. 
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In addition to the enrolment of the glycolytic metabolism, the impairment of cancer 
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Therefore, similar to nutrient diffusion, cellular metabolism dominantly affects the 
tumour microenvironment as the concentration and consumption of oxygen and the 
interstitial pH levels inside the tumour depend on the prevalent metabolism.  
To model the distribution of nutrient, oxygen and acidity in tumour microenviron- 
ment, we adopted the model proposed by Molavian et al. [Molavian et al. 2009]. In 
their model, Molavian et al. used a mathematical approach to find the pH level as a 
function of distance from a blood vessel.  They reproduced the biological results of 
Helmlinger et al. [Helmlinger et al. 1997], and modeled the metabolic toggling of 
cancer cells between respiration and glycolysis. Their explanation of the metabolic 
spatial gradient can justify the observed plateau in pH graph (Figure 8). Their 
scenario is as follows: in the normoxic perivascular regions, respiration is the 
dominant employed metabolism while the recruitment of glycolysis increases as the 
distance from the vessel and the level of hypoxia increase. Thus at intermediate 
distances from blood vessels the cell metabolism is a combination of respiration and 
glycolysis and cells entirely switch to a glycolytic metabolism in anoxia (Figure 8) 
[Molavian et al. 2009].  
According to Michaelis-Menten kinetics, the consumption of oxygen and glucose 









Where PO and PG are the consumption of oxygen and glucose, r is the ratio of 
glucose consumption to oxygen consumption, kO and kG are the Michaelis-Menten 
constants, CO is the concentration of oxygen, and f1 and f2 are adjustment functions 
that control metabolism switching between respiration and glycolysis [Molavian et 
al. 2009].  
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Figure 8: Experimental and simulated plots for pH and pO2. The pH level decreases 
as the distance from the blood vessel increases. Similar to pH, the concentration of 
oxygen decreases as the distance from the vessel increases so that in 300 µm from 
the blood vessel the level of oxygen is almost zero. Inset graph shows the ratio of 
oxygen consumption to glucose consumption. The figure is adapted from Molavian 
et al 2009.   
 
 
The steady state solution of the partial differential equation determines the 





2Ci = Pi    (32) 
and the steady state of Equation (32) reads for:  
Pi +Di∇
2Ci = 0    (33) 
where Ci is the concentration of chemical i, Di is the diffusion constant of chemical i, 
and Pi is the production or consumption of chemical i.  
We have expanded this model to match the layout of the current lattice of tumour 
cells so that there is a frame of vessels surrounding cancer cells (as boundary 
conditions in Equation 33) and chemicals diffuse into the tissue according to the 
discretized format of Equation (32). Hence at each time step of simulation the 
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discretized diffusion equation for each chemical reads for: 
Pi, j +D(
Ci, j+1 − 2Ci, j +Ci, j−1
∆x
+
Ci+1, j − 2Ci , j +Ci−1, j
∆y
) = 0      (34) 
where Ci,j and Pi,j respectively shoes the concentration and production (consumption) 
of species in position (i,j) of the lattice. The spatial layout of our square lattice 
model requires the equality of ∆x and ∆y. The diffusion constants of each species 
into the tissue and permeability constants of each species through the blood vessel 
are listed in Table (11). 
 
Table 11: Diffusion and permeability constants and intravenous concentration of 
chemicals. Regenerated from Molavian et al. [Molavian et al. 2009]. 
  
Compound D (cm2/s) μ (cm/s) Intravenous Concentration (mM) 
O2 
1.46 e−5 
[Nicholas MG and Foster 1994] 
3.0 e−5  [Crone and Levitt 1963] 6.5 e−2  [Molavian et al. 2009] 
Glucose 1.10 e−6  [Casciari et al. 1988] 3.0 e−5  [Crone and Levitt 1963] 7.5 e−1  [Molavian et al. 2009] 
CO2 8.9 e−7    [Molavian et al. 2009] 3.0 e−5  [Crone and Levitt 1963] 1.7          [Molavian et al. 2009] 
Glutamine 1.1e−6       [casciari et al. 1992] 3.0 e−5  [Crone and Levitt 1963] 3.98 e−5 [Molavian et al. 2009] 
Bicarbonate − 2.2 e−7    [Molavian et al. 2009] 1.7 e−5            [Chan et al. 1983] 15           [Molavian et al. 2009] 
Lactate − 1.9 e−6       [casciari et al. 1992] 1.2 e−4  [Crone and Levitt 1963]         2             [Bell et al. 1968] 
H + 1.9 e−6            [Fatt et al. 1998] 1.2 e−4  [Crone and Levitt 1963] 3.98 e−5       [Bell et al. 1968] 
Cl − 2.26 e−7   [casciari et al. 1992] 1.2 e−4  [Crone and Levitt 1963] 1.05 e+2       [Bell et al. 1968] 






4.3. Implementation of cell division, pushing 
algorithm and cellular metabolisms in cellular 
automata model 
Following flowchart demonstrates the implementation of cell division, and Pushing 
algorithm as described before. The type of the cells, distribution of the nutrients and 
pH, and previous state of the cell step in during different parts of the algorithm and 
strongly affect the fate of the cell (Figure 9). 
 
4.3.1. The effect of ECM on tumour growth of single-
type cells 
The following figure (Figure 10), illustrates the effect of ECM absence on our 
simulated tumour. In order to clarify the Impact of the ECM, the distribution of 
nutrients and pH as well as the pushing mechanism are neglected. The tumour is 
assumed to contain a single type of cells in following results. Therefore, cancer cells 
are dividing according to their initial states and availability of vacancies in 
neighbouring positions.  The layout of the generated tumour completely matches the 
prediction. Since the initiating cells are located in the centre of the lattice and the 
division algorithm selects the vacancies either horizontally or vertically the tumour 

















Figure 10: Tumour growth without considering the effect of ECM, nutrients and pH 
distribution, and Pushing algorithm. The vacancies selection in a horizontal or 





The presence of ECM modifies the tumour 2-D layout to a more circular shape. 
Moreover, the restrictions on the pressure and adhesion levels lead to the appearance 
of empty spots inside the tumour where the ECM is not in a proper range, hence the 
cells can not locate in those positions due to the high levels of pressure or inadequate 
adhesion. Following figure (Figure 11) shows the simulated tumour of single type of 
cancer cells in a lattice with randomly assigned ECM. The asymmetric layout is due 
to the stochastisity of the simulation. To illustrate the effect of the ECM, the pushing 
algorithm is inactivated and nutrients and pH distributions are neglected.  
 
Figure 11: Tumour growth affected by ECM. Pushing algorithm is inactivated as 





4.3.2. The effect of pushing on single-type cell tumour 
growth  
The pushing algorithm enables the surrounded cell to proliferate. Hence in a 
simulation with activated pushing algorithm more proliferating cells are dividing 
simultaneously. Thus the apparent prediction is that the colony size of a pushing-
activated tumour is larger than an inactivated-pushing tumour during the same time 
scale. Comparison of Figure (12) with Figure (11) supports this prediction. In this 
figure the simulation is run for a pushing-activated tumour. The effect of ECM, and 
nutrient, and pH distribution are neglected. The empty spots will be filled if we run 
the simulation for a longer period.  
 
Figure 12: Tumour growth affected by pushing algorithm. ECM is inactivated as 
well as the effect of nutrient and pH distribution. Comparison of this result with 






4.3.3. The effect of nutrients and pH distribution on 
single-type cell tumour growth 
The distribution of nutrients and pH affects the cancer cell division, differentiation, 
death, and metabolism. Considering the type of residing cell, the concentration of 
oxygen and acidity at each grid of lattice determines the probabilities of possible 
transitions. However, in the early stages the viability, quiescence or proliferation of a 
cell is determined by hypoxia and acidity intensity of the tumour microenvironment. 
The following figures (Figure 13) show growth of tumours under conditions of 
symmetric and asymmetric distribution of nutrients. Apparently, under the 
asymmetric distribution of nutrients the tumour is skewed to the vessel that is rich in 
nutrients whereas the low concentration of nutrients in other parts results in the 
quiescence of residing cells.  
 
 
4.3.4. Implementation of different phenotypes of cancer 
cells into the cellular automata model 
In the presented 2D cellular automata model, we implemented tumour 
heterogeneities by introducing two basic groups of cancer cells: cancer stem cells 
that express CD 133+ in biological experiments and non-stem cancer cells that are 
recognized as CD133- cancer cells in biological experiments. According to the 
aforementioned transition pathways, the first four phenotype of cancer cells, S, P1, 
P2, and P3, are assigned to cancer stem cells whereas P4, P5, P6, and M cells are 
signed to presents the non-stem cancer cells. To bring the double species-cellular 
automata model close enough to the aforementioned 8 species model of cancer cells, 
we add another characterization of age to the cancer cells so that a cancer cells with 
age of 1 represent a P1 cell and a cancer cell with age of 7 represents a M cell. Age 0 
is assigned to S cells. Figure 14 shows the results of implementing two types of 
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cancer cells in cellular automata model.  
 
Figure 13: Tumour growth under symmetric (first) and asymmetric (second) 
distribution of nutrients. The tumour growth is skewed from the vessels with 
nutrients concentration less than minimum requirements of proliferating cells. Both 
tumours are generated from single-type of cancer cells located at the centre of the 
lattice. The concentration of oxygen and glucose are 6.5*10-2 mM and 7.5*10-1 mM  
in vascular frame for the first image. The concentration of oxygen is different in four 
vessels of the second image and is 8.5*10-2 mM, 5.5*10-2 mM, 5.5*10-2 mM, 5.5*10-2 
mM  for upper, lower, left and right vessels respectively. The concentration of 









Figure 14: Implementation of different phenotypes of cancer cells in 2D cellular 
automata model. Red, blue and green squares are representing non-stem cancer 
cells, Cancer stem cells and empty spots respectively. The transition rates for this 




4.4. Results and Discussion 
Recalling the results for transition pathways for each microenvironmental region, 
herein, the implementation procedure and the obtained realization are presented in a 
forward model and discussed.  
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4.4.1. Summarizing the transition rates for each 
microenvironmental region  
Table (12) summarizes result sets of transition rates in different microenvironmental 
regions. Presented values are the average of transition rates presented in Tables (7-
10) over each region. Considerable distance among loci of results for different 
regions (Figures 4-7) suggests that even the average of each set can characterize the 
whole set distinctly. We have implemented the following values as the transition 
rates in the 2D cellular automata model.  
 
Table 12: The transition rate for different microenvironmental regions.  
 
Average Hypoxic Region Acidic Region Hypoxic-acidic Region Normal Region 
ρS 0.693147 0.693147 0.693147 0.693147 
ρP 0.693147 0.693147 0.693147 0.693147 
r -0.382927 -0.400000 0.064706 -0.522222 
r1 0.115854 0.000000 0.335294 0.077778 
r2 0.385366 0.600000 0.394118 0.322222 
r3 0.498780 0.400000 0.270588 0.600000 




We implemented the above-mentioned transition rates into the cellular automata 
model. The cellular automata also consider a randomly assigned extracellular 
matrix. The function of this matrix in the model is as discussed before; each grid in 
the cellular lattice is able to reside a cell if the relevant value of ECM matrix for this 
grid is in appropriate ranges to provide necessary adhesion while keeping the 
pressure low enough. The values of ECM grids are checked during cell division and 
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pushing mechanisms.  
In addition to the ECM and cellular heterogeneities, the distribution of nutrient and 
pH affect the tumour growth. A cancer cell is forced to quiescent state or death if the 
concentration of nutrients is not enough for proliferation or survival. Therefore, 
asymmetric distribution of nutrients forms the morphological alterations in tumour 
growth. As demonstrated in the previous section, inadequate level of oxygen 
concentration in one side of the lattice frame, for example, causes the tumour to 
skew to the direction that can provide sufficient level of nutrient for cell survival and 
growth. Herein, the realizations of the tumour growth exposed to simulated tumour 
microenvironment are presented. The results confirm the prediction of previous 
chapter.  
Figure (15) shows the distribution of pH and oxygen and the consumption of 
glucose and oxygen by tumour cells. In this realization the concentrations of 
nutrients in vascular frame are asymmetric so that the tumour lattice is exposed to 
normal, acidic and hypoxic-acidic conditions in the same lattice.  The distribution of 
pH (up left), oxygen (up Right) and the consumption of glucose (down left) and 
oxygen (down right) are resented in Figure (15). Due to the Impact of cellular 
metabolism on pH distribution, the tumour is visible in the lattice representing the 
pH distribution (up left).   
Figure (16) and (17) show the produced tumour exposed to the microenvironmental 
conditions illustrated in Figure (15).  
The color code for the lattice presented in Figure (16) is aimed to highlight the 
tumour heterogeneities regards to the seven introduced phenotypes of cancer 
progenitor cells, P1, P2, P3, P4, P5, P6, and M cells. As demonstrated by colors in 
figure (16), maturity of cancer cells is more likely in normal regions than hypoxic-
acidic or acidic parts. On the other hand, the acidic region promotes the stem-like 
phenotype of less mature progenitors, P1, P2, P3, through differentiation of cancer 
stem cells, while acidic-hypoxic region up regulates the self-renewal of S cell. Table 






Figure 15: The distribution of pH (up left), oxygen (up Right) and the consumption 
of glucose (down left) and oxygen (down right). In this realization the lattice 
includes are three microenvironmental regions of hypoxic-acidic (right quarter of 
lattice), acidic (upper quarter), and normal (almost left and lower quarter). Due to 
the Impact of cellular metabolism on pH distribution, the tumour is visible in the 









Figure 16: Tumour heterogeneities due to the microenvironmental conditions. 
Presented lattice is the tumour grown under the microenvironmental conditions 
shown in Figure (15). Lower and left quarters of the tumour are exposed to the 
normal conditions while right and upper quarters are exposed to acidic-hypoxic and 
acidic microenvironmental conditions respectively. Values of grids that interpreted 
as colors show the residing cell phenotype so that value 1 associates with P1 cells 
and 7 represent an M cell. As demonstrated by colors, the maturity of cancer cells is 
more likely in normal regions. Furthermore, The acidic region promotes the stem-
like phenotype of less mature progenitors, P1, P2, P3, through dedifferentiation of 




Figure (17) focuses on the S cells in cancer cell population. S cells as the only 
phenotype that is able to self-renew, symmetrically and asymmetrically differentiate 
is different from other stem-like phenotypes presented in the model. Normal regions 
host smaller population of S cells than acidic or acidic-hypoxic regions. This figure 
supports the argument concluded from recent experimental observations that acidic 





Figure 17: The heterogeneity in tumour exposed to microenvironmental conditions 
presented in Figure (15). S phenotype of cancer cells (denoted in red) is promoted in 






Figures (18-20) sow the results for another realization with the same constrains on 
nutrient and pH concentration. In this realization, we studied the tumour growth for 
a longer period. As demonstrated in Figures (18-20), the results of this realization 
confirm the conclusions of the aforementioned realization. However, longer period 





Figure 18: The distribution of pH (up left), oxygen (up Right) and the consumption 
of glucose (down left) and oxygen (down right). In this realization the lattice 
includes are three microenvironmental regions of hypoxic-acidic (right quarter of 
lattice), acidic (upper quarter), and normal (almost left and lower quarter). Due to 
the Impact of cellular metabolism on pH distribution, the tumour is visible in the 
lattice representing the pH distribution (up left). Longer period of realization time, 






Using a color code for the tumour growth under conditions presented in Figure (18), 
Figure (19) highlights the tumour heterogeneities regards to the seven introduced 
phenotypes of cancer progenitor cells, P1, P2, P3, P4, P5, P6, and M cells. As 
demonstrated by colors in Figure (19), maturity of cancer cells is more likely in 
normal regions than hypoxic-acidic or acidic parts. Similar to presented results in 
Figure (16), the acidic region promotes the stem-like phenotype of less mature 
progenitors, P1, P2, P3, through differentiation of cancer stem cells, while acidic-
hypoxic region up regulates the self-renewal of S cell. Table (12), summarized 
results of previous chapter, supports the produced results. 
Figure 19: Tumour heterogeneities due to the microenvironmental conditions. 
Presented lattice is the tumour grown under the microenvironmental conditions 
shown in Figure (18). Lower and left quarters of the tumour are exposed to the 
normal conditions while right and upper quarters are exposed to acidic-hypoxic and 
acidic microenvironmental conditions respectively. Values of grids that interpreted 
as colors show the residing cell phenotype so that value 1 associates with P1 cells 
and 7 represent an M cell. As demonstrated by colors, the maturity of cancer cells is 
more likely in normal regions. Furthermore, The acidic region promotes the stem-
like phenotype of less mature progenitors, P1, P2, P3, through dedifferentiation of 
cancer cells, while acidic-hypoxic region up regulates the self-renewal of S cell. 




Figure (20) focuses on the S cells in cancer cell population for this realization. As 
demonstrated in Figure (20), normal region hosts smaller population of S cells than 
acidic or acidic-hypoxic regions. This figure supports the argument concluded from 
the results of the recent experimental observations that suggest the promotion of 




Figure 20: The heterogeneity in tumour exposed to microenvironmental conditions 
presented in Figure (18). S phenotype of cancer cells (denoted in red) is promoted in 









In spite of the ever-increasing attempts to treat cancers, it’s still one of the main 
challenges of modern medicine. Proposing the tumour heterogeneities and the 
dominant role of some subpopulations of tumour cells to promote the tumour 
progression along with the lethal damage of normal cells in tumour vicinity from the 
cancer therapies, suggest the importance of cell targeting to design a successful 
cancer treatment.   
In presented model, we proposed that the tumour microenvironmental condition 
plays a critical role in forming tumour heterogeneities. Assuming eight distinct 
phenotype of cell in cancer cell population, we studied the effect of hypoxia, acidity 
and the coincidence of hypoxia and acidity on different division pathways of cancer 
cells. We built a cellular automata model equipped with a pushing mechanism under 
the distribution of nutrient and pH and extracellular condition. This forward model 
visualizes the effect of microenvironmental factors on tumour growth and 
heterogeneities. The results can provide a hint on which subpopulation(s) of cancer 
cells may be the critical group to target based on instantaneous state of the tumour. 
The promotion of cancer stem cell phenotype in acidic region through the promotion 
of dedifferentiation of progenitors and asymmetric differentiation of S cells leads in 
the increased population of cancer stem cells from P1, P2, and P3 phenotypes. The 
predicted down regulation of self-renewal of S cells results in the suppression of this 
phenotype in acidic regions.  
Similar to acidity, hypoxia upregulates the stem-like phenotypes among cancer cell 
population. However, the self-renewal of S cells in hypoxic regions is more likely 
than acidic areas. The promotion of dedifferentiation rate of progenitors in hypoxia 
is relatively higher than other microenvironmental regions.  
The self-renewal of S cells seems to be maximally promoted in acidic-hypoxic 
regions. On the other hand, the dedifferentiation rate of cancer progenitors is also 
upregulated n this region. Consequently, the majority of S phenotype subpopulation 
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is residing in acidic-hypoxic region.  
Further biological experiments are needed to validate the predictions of our model 
about the dynamics of tumour heterogeneities. Such experiments may investigate the 
synergistic effect of hypoxia and acidity on cancer cells. Using an accurate cell 
sorting method to distinct cancer cells based on the expression of stem cell markers 
such as CD133+ and pluripotency potentials may be useful.    
One potential direction of extension of the model is to consider different rates of 
transitions for cancer progenitors. The differentiation of P3 cells, as the most mature 
phenotype of cancer stem cells, to P4 cells, as the least mature phenotype of non-
stem cancer cells is of special interest. Certainly, a larger scale of cellular automata 
modeling can obtains better prediction of reality.  
In a larger scale, the model can be improved by considering the effect of cancer 
therapies such as anti-angiogenic therapies or treatments to normalize the 
vasculature inside the tumour as well as proposed therapies to lower the acidity of 
the tumour microenvironment by introducing a auxiliary buffering system 
[Molavian et al. 2009]. The effect of chemo and radiotherapy of cancer cells with an 
emphasis on targeting specific subpopulations of cancer cells can be added to 
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